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Abstract 
Dietary cysteine can replace up to 40% of the methionine requirement in the diets of both 
men and rats. Various experiments were designed to examine this phenomenon, 
including measurements of transsulfuration flux in isolated hepatocytes, hepatic enzyme 
and substrate analysis of sulfur amino acid metabolism, and cystathionine ~-synthase 
(CBS) mRNA. In adult rats fed a high cystine diet for one week, transsulfuration flux 
was decreased by 40% as compared to animals fed a basal diet. This change in flux was 
mirrored by a similar change in CBS activity and mRNA. In young rats fed sulfur amino 
acid supplemented diets for one week, transsulfuration flux measured with 0.1 mM 
methionine fell by over 50% in cystine supplemented animals as .compared to basal and 
methionine supplemented rats. Among the variety of results that followed , CBS activity 
decreased in rats supplemented with cystine compared to high methionine supplemented 
rats by 45%, while CBS mRNA decreased by almost 65% in these two groups. We also 
examined the effect that allosteric regulators S-adenosylmethionine and S-
adenosylhomocysteine had on the enzymes of methionine metabolism. Our results 
indicated that SAM played a crucial role in regulating transsulfuration and remethylation 
of homocysteine via folate. 
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Chapter 1 
1. Introduction to Homocysteine 
The interest in homocysteine metabolism and related fields of research 
has grown almost exponentially in the past several decades (Finkelstein, 2000a). 
Aside from the interrelationship between methionine, homocysteine, and 
cysteine, the areas of interest arise from the roles sulfur amino acid metabolism 
play in folate metabolism, antioxidant effects, and the majority of the methylation 
reactions. 
The metabolism of methionine begins with the transfer of an adenosyl 
group onto methionine via Methionine Adenosyltransferase (MAT), creating S-
Adenosylmethionine (SAM). SAM is known as the body's most biologically 
available methyl group donor, meaning that it can transfer its methyl group to a 
variety of methyl group acceptors, creating S-Adenosylhomocysteine (SAH) and 
adenosine in the process (Fontecave et a/, 2004). SAH Hydrolase rapidly 
converts SAH to homocysteine (Stipanuk, 1986). Together, these reactions 
make up the transmethylation pathway. 
The metabolism of sulfur amino acids can branch at this point in the 
pathway. One branch is known as the remethylation pathway, which, in itself, 
contains two different reactions. The first reaction involves folate metabolism, as 
a methyl group from methyltetrahydrofolate is transferred to homocysteine by 
methionine synthase, recreating methionine. Methyltetrahydrofolate itself is 
produced by the action of Methylenetetrahydrofolate Reductase (Finkelstein eta/, 
1978). The alternate routing of remethylation arises from the donation of a 
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methyl group from betaine to homocysteine via Betaine:Homocysteine 
Methyltransferase, producing dimethylglycine and methionine (Pajares and 
Perez-Sala, 2006). 
The other branch that homocysteine can traverse is that of the irreversible 
transsulfuration pathway. Homocysteine is condensed with serine to produce 
cystathionine through the action of Cystathionine 13-Synthase (Finkelstein et a/, 
1974). This cystathionine is then acted upon by Cystathionine y-Lyase, 
producing cysteine, which can then proceed into a variety of different fates 
(Finkelstein eta/, 1974). The whole of methionine metabolism can be seen in 
Figure 1.1 
1.1 Homocysteine and Health 
Another reason for the increase in homocysteine research has been the 
links discovered between increased plasma homocysteine concentrations and a 
variety of diseases, such as cardiovascular disease (Humphrey et a/, 2008), renal 
disease, and different cognitive disorders. 
In a metabolic pathway as complex as homocysteine's, a variety of inborn 
errors can occur, leading to a build-up of homocysteine with deleterious health 
effects. The most common of these inborn errors is a deficiency in CBS activity, 
first reported by Carson (Bittles and Carson, 1981 ), resulting in excessively 
increased concentrations of homocysteine and methionine. In addition to the 
abnormal plasma thiol concentrations, CBS deficient patients also tend to suffer 
from dislocations of the ocular lens, mental retardation, skeletal deformations, 
2 
Figure 1.1: Mammalian hepatic methionine metabolism. 
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and cardiovascular lesions, the latter of which are frequently a cause of death 
(Mudd eta/, 1995). 
The second most common types of errors in homocysteine metabolism 
occur in the remethylation pathway. The errors in this pathway can take several 
forms ranging from a genetic defect in metabolism to defects in folic acid or 
cobalamin transport. Whatever the defect, the displayed symptoms are 
essentially the same as the CBS deficiencies, with the exception of low 
methionine concentrations versus the high methionine concentrations of CBS 
deficiency. 
Whether or not the defect is in transmethylation or in transsulfuration , both 
errors in homocysteine metabolism result in vascular lesions, leading to the death 
of the patient. This finding led to the speculation that the cause of the vascular 
lesions was, in fact, due to high circulating homocysteine concentrations. This 
speculation was tested by examining two types of CBS deficient patients, those 
that responded to pyridoxine treatment and those that did not. The patients that 
responded to pyridoxine treatment had decreased plasma homocysteine 
concentrations when compared to the non-responders (Mudd et a/, 1985). In 
these non-responding patients, there was also a 50% higher risk of a vascular 
event occurring after thirty years. Multiple other studies have since concluded 
that high concentrations of homocysteine are linked to an increased risk of 
vascular disease (Wilcken eta/, 1997; Yap eta/, 2000). 
With the discovery that very high plasma homocysteine concentrations 
caused blood vessel lesions in a small population of patients with inborn errors, it 
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was considered that mild increases in homocysteine concentrations could 
potentially increase the risk of cardiovascular disease in the population at large. 
This mild homocysteinemia was defined as a plasma homocysteine conc~ntration 
of 15 to 25 IJM, as compared to accepted normal homocysteine concentration 
ranges of 5 to 15 IJM (Green and Jacobson, 1995). 
In 1995, a meta-analysis of 27 studies provided a strong link between mild 
homocysteinemia and increased risk of CVD (Boushey et al, 1995). This meta-
analysis of over 4000 subjects concluded that increased homocysteine 
concentrations were a risk factor for cardiovascular disease, independent of all 
other known risk factors; in fact, mild homocysteinemia has been classified as 
having the same risk as diabetes (Sparks et al, 2003) and mild increases in 
plasma cholesterol concentrations (Boushey et al, 1995). Further studies have 
indicated that 20-30% of all cardiovascular disease, cerebrovascular disease, 
and peripheral vascular disease sufferers have a mild elevation in homocysteine. 
The mechanism by which a mild elevation in homocysteine can increase 
risk for a thrombotic event occurring is still unclear, although many mechanisms 
have been proposed. These mechanisms have been proposed to include 
homocysteine-induced oxidative stress (Wilcken et a/, 2000), reduced 
endothelial-dependant vasodilation (Tawakol et a/, 1997), protein 
homocysteinylation and/or acylation (Jakubowski, 2000), or an inhibition of the 
synthesis of nitric oxide (Upchurch eta!, 1997). 
Despite these theories, it is possible that any or none of them are true - in 
fact, the increased homocysteine concentrations could simply be an 
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epiphenomenon that reflects the real underlying mechanism. One study which 
used apolipoprotein E (ApoE) deficient mice, which develop spontaneous 
atherosclerotic lesions, thereby allowing the investigators to examine the effect of 
nutrition on the progression of lesion formation , suggests that it may not be high 
homocysteine concentrations that increase lesion formation , but high methionine 
concentrations. The lesions formed in the high methionine groups, but with 
normal plasma homocysteine concentrations, were far larger than those lesions 
found in the high homocysteine, low methionine mice, indicating that the high 
methionine concentrations accelerated lesion formation (Troen et a/, 2003). 
Whether homocysteine concentrations exacerbate this condition , or remain just a 
marker of lesion development, has yet to be determined. 
In addition to any effects that homocysteine concentrations may have on 
cardiovascular disease, there is also mounting evidence that homocysteinemia 
may be linked to a decrease in cognitive function and an increase in Alzheimer's 
disease and dementia. Riggs et a/ (1996) discovered that an increase in total 
plasma homocysteine concentrations was associated with a decrease in spatial 
copying abilities. In 1997, Joosten eta/ found that there were increased plasma 
homocysteine concentrations in Alzheimer's patients compared to both healthy, 
elderly patients and control hospitalized subjects. Finally, it was also found that 
there was a positive correlation with depressed elderly patients and plasma 
homocysteine concentrations (Bell et a/, 1992). Whether the total plasma 
homocysteine is a cause of the neurodegenerative damage or simply an indicator 
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of folate status, which is also important for brain function (Rosenburg and Miller, 
1992), remains to be seen. 
1.2 The Metabolism of Sulfur Amino Acids 
The metabolism of methionine and its related compounds is extremely 
complex. For simplification, the pathway has been broken into three different 
sections - the transmethylation pathway, the remethylation pathway, and the 
transsulfuration pathway. 
1.2.1 Transmethylation Pathway 
The transmethylation pathway denotes the reactions that produce and use 
SAM, a major biological methyl group donor. These reactions include those 
catalyzed by Methionine Adenosyltransferase, a variety of methyltransferases, 
and SAH Hydrolase. 
1.2.1.1 Methionine Adenosyltransferase 
The first reaction of the transmethylation pathway is the synthesis of S-
Adenosylmethionine (SAM) by Methionine Adenosyltransferase (MAT) from 
methionine and adenosine triphosphate (ATP). The production of SAM is a two-
step process that begins with the synthesis of SAM and tripolyphosphate (PPPi). 
Both products remain attached to the enzyme until the completion of the second 
step, which is the hydrolysis of the tripolyphosphate to inorganic phosphate (Pi) 
and pyrophosphate (PPi) (Mudd; 1963). This second step is the rate-limiting step 
in the overall reaction (Sanchez del Pino eta/; 2000). 
Two genes are responsible for the coding of MAT: MAT1A and MAT2A 
(Mato eta/; 1997). MAT2A encodes for the MAT II isoenzyme, and is present 
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only in extrahepatic tissues and in fetal liver (Gil eta/, 1996). MAT II is a tetramer 
of two catalytic a2 subunits and two regulatory 13 subunits (Halim et al, 1999) that 
is inhibited by its product, SAM, and has a low Km for methionine (Finkelstein, 
2000b). In fact, at physiological concentrations of methionine, MAT II is saturated 
with its substrate, which results in a relatively steady concentration of SAM in 
extrahepatic tissues (Finkelstein, 2000b). 
The second gene responsible for MAT synthesis, MAT1A, is present in the 
adult liver, and produces two isoenzymes, MAT I and MAT Ill (Kotb, M and 
Geller, AM, 1993; Torres eta/, 2000). MAT I has a low Km for methionine in the 
liver, and is responsible for the basal level of SAM synthesis to support 
polyamine synthesis, etc (Finkelstein, 1990). This particular isoenzyme is a 
tetramer of a1 subunits, and is inhibited by SAM (Hoffman, 1983). 
The other hepatic isoenzyme, MAT Ill , is a dimer of a1 subunits (Hoffman, 
1983). In contrast to MAT I and II , MAT Ill has a high Km for methionine, and is 
activated by its product, SAM (Finkelstein, 2000b). During times of high 
methionine, such as the ingestion of a high protein meal, this enzyme is 
responsible for the clearance of this amino acid. In fact, approximately 50% of 
ingested methionine is catabolized by the MAT IIIII combination (Corrales et a/, 
2002). The SAM activation further allows an increase in the activity of MAT Ill in 
order to clear the excess methionine. Once the methionine becomes relatively 
depleted in the liver, the MAT Ill activity and SAM concentrations will decrease. 
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1.2.1.2 S-Adenosylmethionine 
The product of the MAT reaction , SAM, has been estimated to be the 
second most common biological reaction co-factor, after ATP (Lu, 2000). The 
majority of biological methylation reactions (approximately 85%) (Mudd and 
Poole, 1975), occur in the liver, where most of methionine catabolism occurs. 
SAM is also chemically inclined to donate its methyl groups, as its high-energy 
sulfonium ion results in a predisposition of the attached carbons towards 
nucleophilic attack (Lu, 2000). These methylation reactions result in the creation 
of S-Adenosylhomocysteine (SAH), which then acts as feedback to inhibit most of 
the enzymes responsible for methylation (Mato eta/, 1997). 
Apart from the methylation reactions, SAM metabolism is also involved in 
polyamine synthesis. In this pathway, decarboxylated-SAM is produced via SAM 
decarboxylase. The aminopropionyl group of the decarboxylated SAM can then 
be transferred to putrescine to produce spermidine, and to spermidine, to 
produce spermine (Finkelstein, 1990). A product of these reactions is 
methylthioadenosine, which can eventually be recycled back to methionine. 
Polyamine synthesis usually accounts for no more than 5% of methionine 
catabolism in liver (Mudd and Poole, 1975). 
Re'cently, much work has been done on the clinical utility of SAM as a 
treatment, especially in diseases of the liver, such as alcoholic cirrhosis. A 
decrease in MAT activity has been found in cirrhotic liver. Altered DNA 
methylations may also occur which may also contribute to the etiology of the 
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disease (Avila et a/, 2000; Krahenbuhl et a/, 2000; Lieber et a/, 1994; Varela-
Moreiras eta/, 1995). 
1.2.1.3 Glycine N-Methyltransferase 
Despite the fact that there are a large number of methyltransferases that 
require SAM as a methyl group donor, the enzyme Glycine N-Methyltransferase 
(GNMT) stands out for the role it plays in the clearance of high methionine loads, 
as well as its role in the regulation of SAM:SAH ratios. Like other 
methyltransferases, GNMT catalyzes the transfer of a methyl group from SAM. 
In this instance, GNMT transfers the methyl group onto glycine, which forms both 
SAH and sarcosine. The SAH that is produced will continue on through the 
transmethylation pathway, while sarcosine, which currently has no known 
physiological role, can be recycled by sarcosine oxidase back into glycine (Cook 
and Wagner, 1984). 
The rat isoform of the GNMT enzyme has a significantly lower Km for both 
SAM and glycine than its counterpart in other species. For example, in the rat, 
the Km for SAM and glycine are 0.05 mM and 0.29 mM, respectively; however, 
for humans, the Km for SAM and glycine are 0.27 mM and 6.3 mM (Ogawa eta/, 
1993). 
GNMT activity can theoretically be altered via the binding of 5-
methyltetrahydrofolate. The binding of this folate co-factor causes a decrease in 
the GNMT activity (Wagner et a/, 1985), possibly due to the 5-
methyltetrahydrofolate competing for the SAM binding site (Ogawa et a/, 1998). 
The folate binding will also prevent phosphorylation of GNMT, which would 
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normally double the activity of the enzyme (Wagner eta/, 1989). It is thought that 
this binding may prevent unnecessary breakdown of SAM by GNMT in order to 
preserve methyl groups for other essential transmethylations at times when 
methionine is low. 
1.2.1.4 SAH and SAH Hydrolase 
SAH, the product of all SAM methylation reactions, is an inhibitor of the 
majority of these reactions; therefore, there must be mechanisms by which to 
eliminate the increasing amounts of SAH in order to ensure that the SAM 
methylation reactions can continue. Currently, there are two means by which 
SAH is eliminated from cells. 
The first of these means occurs when SAH is transported out of the cells 
into the blood, where it can be cleared by the kidney (Duerre et at, 1969). 
Secondly, SAH Hydrolase can act upon SAH. SAH is also known to bind to 
intracellular proteins, thereby decreasing the amount of free SAH (Svardel and 
Ueland, 1987). 
SAH Hydrolase catalyzes the reversible reaction that converts SAH and a 
water molecule to homocysteine and adenosine. The SAH Hydrolase contains 
NAD+. Though this reaction is freely reversible, its equilibrium heavily favours 
SAH synthesis; however, in vivo, both adenosine and hbmocysteine are rapidly 
metabolized (de Ia Haba and Cantoni, 1959), with adenosine being metabolized 
by adenosine kinase and adenosine deaminase, and homocysteine entering 
either the transsulfuration pathway or the remethylation pathway, or being 
exported out of the cell. These factors ensure that SAH is efficiently removed. 
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Due to the fact that SAH Hydrolase is heavily involved in the reduction of 
SAH concentrations intracellularly, it has become a favoured target of 
pharmaceutical treatments. By inhibiting SAH Hydrolase, a patient's intracellular 
SAM:SAH ratio is lowered, thereby causing an inhibition of methylation reactions, 
which results in various effects, including antiviral (Bader et a/, 1978), 
antiparasitic {Tseng eta/, 1989), and possibly anti-cancer effects (Chiang, 1981 ). 
1.2.1.5 Homocysteine 
Once homocysteine is produced by SAH Hydrolase, it has several 
possible fates. Firstly, homocysteine can be transported in the plasma. 
Homocysteine has several forms in plasma, including a free form, a mixed 
disulfide, and bound to albumin. Secondly, the homocysteine can proceed to 
cysteine through the transsulfuration reactions, and from cysteine, can lead to 
other areas of metabolism, such as taurine synthesis, glutathione synthesis, or 
protein synthesis. Alternatively, homocysteine can be directed towards the 
remethylation pathway, which recycles homocysteine back to methionine. 
1.2.2 Remethylation Pathway 
There are two mechanisms by which methionine can be regenerated . The 
first involves folate metabolism, while the second mechanism uses a methyl 
group from betaine. 
1.2.2.1 Methionine and Folate Metabolism 
Methionine synthase catalyzes the transfer of a methyl group from MTHF 
to homocysteine, resulting in the formation of tetrahydrofolate (THF) and 
methionine. This large, cytoplasmic protein is present in most cells in the body, 
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and requires cobalamin as a cofactor (Chen et at, 1995). The THF that is formed 
can then be used by the cells for the synthesis of purines and pyrimidines. 
The MTHF necessary for methionine synthase can come from intracellular 
sources as well as from the blood. The enzyme Methylenetetrahydrofolate 
Reductase produces the intracellular MTHF from methylenetetrahydrofolate, 
which can be produced from THF by Serine Hydroxymethyltransferase (SHMT). 
MTHFR is an important regulatory enzyme in both folate and 
homocysteine metabolism. This dimer, which contains identical 77 kDa subunits 
(Daubner and Matthews, 1982), contains a catalytic region in the N-terminal, 
which can be activated allosterically through the binding of SAM to a specific 
regulatory region in the C-terminal. Each subunit is also associated with a non-
covalently bound flavin adenonucleotide molecule (FAD), which is necessary for 
the transfer of a methyl group from methylenetetrahydrofolate (Daubner and 
Matthews, 1982). 
While a large number of mutations in the MTHFR enzyme have been 
discovered in humans, the Ala222Val mutation is particularly common in 
Caucasians, with an incidence of approximately 12% of the Quebec population 
(Frosst et at, 1995). This mutation results in decreased activity in fibroblasts and 
increased susceptibility to heat-sensitive deactivation (Engberson et at, 1995). 
Additionally, this mutation also leads to the dissociation of the FAD compounds 
associated with MTHFR (Matthews et at, 1998). This form of MTHFR has been 
definitively linked to an increased incidence of neural tube defects (Whitehead et 
a/, 1995), and potentially linked to an increased incidence of cardiovascular 
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disease. Individuals with this particular mutation have a higher dietary folate 
requirement. 
1.2.2.2 Methionine and Choline Metabolism 
While the folate-dependent homocysteine remethylation pathway takes 
place in most cells throughout the body, the liver contains an additional enzyme 
(Betaine:Homocysteine Methyltransferase), which is able to remethylate 
homocysteine (Garrow, 1 996). This enzyme is also found , in small amounts, in 
the kidney and the brain of humans (Gaull eta/, 1973). BHMT catalyzes a methyl 
transfer from betaine to homocysteine, producing methionine and 
dimethylglycine; dimethylglycine is a potent inhibitor of BHMT (Finkelstein et a/, 
1972). DMG is further demethylated by DMG dehydrogenase, producing 
sarcosine, which can be converted into glycine. BHMT is a hexamer of a 45 kDa 
protein that has been shown to have a Km of 15-20 1-JM for homocysteine and 50-
60 1-JM for betaine (Stipanuk, 1986). 
In addition to its effects in the homocysteine remethylation pathway, BHMT 
also plays a central role in choline oxidation. Choline, which arises either from 
the diet or as a consequence of the methylation of phosphatidylethanolamine by 
SAM, has three fates: phospholipid incorporation (Li and Vance, 2008), 
acetylcholine synthesis (Amenta and Tayebati, 2008), and oxidation to eliminate 
excess choline (Barak and Tuma, 1983). The committed step of choline 
oxidation is the first step in the pathway, whereby choline dehydrogenase (or 
choline oxidase) coverts choline to betaine aldehyde, which is converted to 
betaine by betaine aldehyde dehydrogenase. 
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1.2.3 Transsulfuration Pathway 
1.2.3.1 Cystathionine f3-Synthase 
The alternative pathway for homocysteine metabolism is through the 
transsulfuration pathway, ·which irreversibly removes the sulfur from the 
methionine cycle. The first step in the transsulfuration pathway is catalyzed by 
cystathionine ~-synthase (CBS), which condenses the homocysteine with serine 
to produce cystathionine. In vivo, th is reaction is irreversible, which, therefore, 
explains why cysteine is considered a conditionally essential amino acid , as 
cysteine may be produced from methionine if sufficient methionine is present. 
In fresh liver extracts, CBS has been shown to exist in a tetrameric form, 
with each subunit having a molecular weight of roughly 63 kDa (Taoka et a/, 
1998). This enzyme has a Km of 1.5-5.0 mM for homocysteine (Kery eta/, 1998) 
and Km of 2.0-3.0 mM for serine (Taoka et a/, 1999). Methionine synthase, 
however, has a Km of approximately 60 !JM for homocysteine (Burke, Mangum, 
and Brodie, 1971), which is significantly lower than the CBS Km. Due to this 
difference in Km's, it would seem that, in vivo, remethylation to methionine is 
favoured over transsulfuration to cysteine. In fact, CBS would only be highly 
active in times of excess homocysteine concentrations, thereby making it an 
essential mechanism for removing excess homocysteine. 
Two necessary co-factors for CBS activity are pyridoxal 5-phosphate 
(P5P) and a heme group. P5P binds serine, thereby increasing its reactivity, and 
allowing for easier transfer of the sulfur group (Mudd et a/, 1970). The heme 
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group interacts with the homocysteine thiol group, which will potentially allow it to 
act with the serine bound to P5P (Taoka eta/, 1998). 
In addition to the tetrameric form of CBS, a dimer of this enzyme, 
consisting of two 48 kDa subunits, was originally discovered in liver samples that 
had been frozen for several weeks (Skovby eta/, 1984). Initially, it was believed 
that this form of the CBS enzyme did not exist in vivo, and was simply a result of 
limited proteolysis in the frozen sample. Recently, however, evidence has been 
brought forward demonstrating that the dimer may be present in vivo under 
oxidizing conditions. The subu!lits of this dimeric form of CBS have been cleaved 
so that they have lost their C termini, which are responsible for the allosteric 
regulation of CBS by SAM (Zou and Banerjee, 2003). This cleaved CBS, 
therefore, no longer responds to SAM, thereby decreasing the activity of the 
tetrameric CBS by about 70% (Shan and Kruger, 1998). 
A mutation in CBS has been found to be the cause of the most common 
form of homocysteinuria (Mudd and Levy, 1969). Almost 50% of these mutations 
are a direct result of a mutation in CBS that prevents any interaction with P5P; in 
such patients, supplementation with vitamin B6 is effective in lowering high 
plasma homocysteine levels (Mudd, 1989). 
1.2.3.2 Cystathionine y-Lyase 
The second transsulfuration enzyme is cystathionine y-lyase (CGL), which 
cleaves cystathionine into cysteine and a-ketobutyrate (Braunstein and 
Goryachenkova, 1984 ). CGL also requires P5P as a co-factor for activity, and 
has a Km for cystathionine of 3.5 mM (Kato eta/, 1966). 
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CGL is absent from certain tissues that contain the CBS enzyme, such as, 
the rat brain and rat adipose tissue (Mudd et a/, 1965). The function of CBS in 
these tissues remains unclear, although a role in H2S production has been 
proposed. 
The cysteine produced by transsulfuration can have several fates. A 
portion will be directed towards protein synthesis, while up to 70% of the excess 
cysteine may be used to make glutathione (Rao eta/, 1990). Glutathione is a key 
agent in the prevention of oxidative damage in the body; in fact, it is the main 
anti-oxidant in cells. Therefore, the increase in transsulfuration activity under 
oxidative conditions to produce cysteine most likely occurs to create glutathione, 
which would combat the oxidative stress. The majority of the remaining cystejne 
will be metabolized to sulfates by the cysteinesulfonate pathway. This pathway 
can lead to one of two different directions; either the cysteinesulfonate can be 
broken into sulfate and pyruvate, which can then be fully oxidized in the Krebs' 
cycle, or cysteinesulfonate will be converted to taurine via a decarboxylation 
reaction. 
1.3 Regulation of Homocysteine Metabolism 
1.3.1 Enzyme Kinetics 
A variety of mechanisms regulate homocysteine and methionine 
metabolism. The first and most basic of these mechanisms focuses on the 
enzyme kinetics of the methionine pathways. From the Km's of the enzymes 
involved, it is apparent that there are two classes of enzymes in respect to 
methionine metabolism -those that strive to conserve methionine, and those that 
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strive to catabolize methionine. Enzymes in each of these groups share common 
characteristics that allow them to be categorized. 
The methionine conservation enzymes all have low Km's for their specific 
sulfur-containing substrates. These enzymes include MAT I and II, SAH 
Hydrolase, Methionine Synthase, MTHFR, and BHMT. On the other hand, the 
methionine catabolizing enzymes have a high Km for sulfur-containing 
substrates, and include MAT Ill, CBS, CGL, and GNMT. 
The different Km's provide a simple regulatory mechanism. At times when 
methionine concentrations are low within a cell, the methionine conservation 
enzymes will function. The transmethylation pathway will synthesize only enough 
SAM for necessary transmethylation reactions, while homocysteine will be 
directed towards remethylation and methionine synthesis, not towards 
transsulfuration. At times when intracellular methionine concentrations are high, 
the methionine catabolizing enzymes will function to ensure that methionine is 
efficiently metabolized. The transmethylation pathway will synthesize SAM in 
excess of what is needed for essential transmethylation reactions; much of this 
excess SAM is used by GNMT. The excess homocysteine that is produced will 
be directed towards transsulfuration, thereby irreversibly removing these sulfur-
containing compounds from methionine metabolism. 
1.3.2 Allosteric Regulation 
SAM is considered to be the allosteric regulator with the greatest impact 
on methionine metabolism. Currently, it is known that high levels of SAM will 
inhibit MAT 1/11 (Finkelstein, 1990), BHMT (Finkelstein and Martin, 1984), and 
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MTHFR (Jencks and Matthews, 1987), while activating MAT Ill (Finkelstein, 
1990) and CBS (Finkelstein et a/, 1975). This interplay of SAM and the various 
enzymes of methionine metabolism has led to the theory of the "SAM switch" -
high levels of SAM will lead to the suppression of the remethylation pathway, and 
a net flux of sulfur into the transsulfuration pathway. A figure representing SAM 
allosteric regulation in methionine metabolism can be seen in Figure 1.2. 
Additionally, it has been shown that SAH also has some allosteric effects 
on the methionine metabolic pathway. SAH inhibits the majority of the 
transmethylases; however, SAH has also been reported to inhibit BHMT while 
activating CBS (Finkelstein , Kyle and Harris, 1974), thereby leading to a net flux 
away from remethylation of homocysteine, and, like SAM, an influx of sulfur will 
enter the transsulfuration pathway. Additionally, it is known that MTHF inhibits 
GNMT in an allosteric manner (Wagner eta/, 1985). 
1.3.3 Redox Regulation 
One of the major results of the transsulfuration pathway is the production 
of glutathione from cysteine. As previously mentioned, glutathione is the major 
intracellular protective agent against oxidative damage; therefore, it is appropriate 
to note that flux through the transsulfuration pathway will increase under oxidative 
stress. 
The activity of CBS will decrease when the reaction occurs in the presence 
of a reducing agent; however, when the "reduced" CBS is placed in an 
environment promoting oxidation, the activity is restored (Taoka et a/, 1998). 
Oxidation has been shown to promote cleavage of the CBS enzyme from its 
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tetrameric form to its dimeric form, thereby creating a CBS enzyme that is highly 
active and free from allosteric regulation (Zou and Banerjee, 2003). 
Additionally, methionine synthase must be maintained in a reduced state, 
as oxidation of this enzyme will decrease its activity. The cobalamin that is an 
integral part of methionine synthase activity is active only when reduced, thereby 
creating the dependency on a reducing environment for methionine synthase 
(Chen et al, 1995). In combination with the CBS redox regulation, an attractive 
theory would be that oxidation leads to a decreased flux through the 
remethylation pathway by decreasing methionine synthase activity while 
increasing the flux through CBS and the transsulfuration pathway, thereby 
producing more cysteine to be used for glutathione production 
1.3.4 Hormonal Regulation 
The role of hormones in the regulation of methionine metabolism still 
remains an active topic of investigation. Recent research has produced new 
understanding of the effects of glucagon and insulin. For example, our lab has 
shown that streptozotocin-treated rats have a lower plasma homocysteine 
concentration than control rats, and that this lowered plasma homocysteine can 
be returned to normal after treatment with insulin (Jacobs et a/, 1998). Our lab 
has further gone on to examine this phenomenon, and has shown that insulin will 
suppress CBS activity and decrease mRNA levels (Ratnam, eta/, 2002). On the 
other hand, glucagon was shown to increase CBS activity and mRNA 
concentrations, which lowers homocysteine levels (Jacobs et a/, 2001 ). 
Hormonal regulation of other enzymes in the pathway are under investigation. 
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Figure 1.2: Allosteric regulation of methionine and homocysteine 
metabolism by SAM. Negative signs indicate that the presence of high SAM 
concentrations decrease enzyme activity, while positive signs indicate an 
increase in activity. It should be noted that SAM both increases and decreases 
SAM Synthase activity, depending on the isoform of the enzyme. 
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1.4 The Methionine-Sparing Effect of Cysteine 
For years, cystine (with cysteine) was known as the only naturally 
occurring amino acid that contained sulfur. The discovery by Mueller in 1923 
(Mueller, 1923; Mueller, 1924) of the existence of methionine, a new sulfur-
containing amino acid, caused many biochemists to question the dietary 
importance of cystine. It was not until 1932, however, that a link was provided 
between cystine and methionine. Having previously proved that adding 
methionine to a methionine-deficient diet caused a rapid increase in body weight 
of rats, Jackson and Block (Jackson and Block, 1932) examined the effect of 
addition of methionine to a cystine deficient diet. Using young male rats (a body 
weight of 60-75 g), they followed the changes in body weight. The rats were fed 
diets that consisted of control amounts of various amino acids but were low in 
methionine and cystine. Cysteine-supplemented diets contained 1.2 g 
cysteine/kg diet, while the methionine supplemented diets contained 2 and 4 
times the molar equivalents of methionine compared to cystine. It was found that 
the addition of methionine or cystine to the cystine-deficient diet immediately 
caused a rapid increase in growth; this was not found in the rats fed diets 
supplemented with other amino acids. The authors suggested that only one of 
the amino acids is indispensable and that one amino acid, either cystine or 
methionine, could be converted by the body into the other. 
With mounting evidence that cystine was not as essential in the diet as 
once thought, Womack, Kemmerer and Rose reported a study in 1937 that would 
end the debate. Using crystalline amino acid diets, they investigated weight gain 
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in rats ingesting four different diets. The first diet contained 0.6% d/-methionine 
with 0.3% cystine; the second diet was supplemented with 0.6% cystine; the third 
diet contained 1.4% d/-methionine; and the final diet used only the basal amino 
acid mixture, and therefore, had no sulfur amino acids present. The rats with the 
methionine-supplemented diets, diets 1 and 3, grew far better than the rats 
lacking the additional methionine. In fact, the rats that ate the diet supplemented 
with cystine alone and the diet lacking sulfur amino acids actually lost weight. 
Therefore, the authors were finally able to conclude that it was, in fact, 
methionine that was indispensable, whereas cystine was a non-essential amino 
acid that could be synthesized by the body. The investigators were also the fi rst 
to speculate that it was possible that cysteine could potentially replace a portion 
of methionine in the diet, yet could not replace the entire methionine component. 
The final word on th is discussion would come from Rama Rao et a/ in 
1961 , in experiments aimed at determining both the effect of tyrosine 
supplementation on phenylalanine requirements as well as cystine 
supplementation on methionine requirements. L-methionine levels were tested at 
0.0%, 0.1 %, 0.2%, 0.3%, and 0.4% in the presence of 0.5% cystine levels in the 
diet. This group demonstrated that the dietary requirement of methionine that 
allowed rats to grow could be reduced from 0.5% to 0.16% of the diet, if cystine · 
were supplemented at a level of 0.34%. 
With the relationship between methionine and cystine definitively proven 
and methionine recognized as the essential sulfur-containing amino acid, 
investigators examined the evidence surrounding potential pathways that might 
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be involved in the methionine-sparing effect. Studies by Falin and Marenzi, 
followed by Butz and du Vigneaud in the 1930's led to the discovery of 
homocysteine. It was later shown that homocysteine, cysteine, and methionine 
were linked in a common pathway. Research by du Vigneaud, Dyer, and 
Harmon (1934) attempted to determine the dietary effect of homocysteine in rats. 
They employed four different diets; a basal diet, a cystine-supplemented diet 
(0.3g/1 OOg of diet), a homocystine supplemented diet (0.675 g/1 00 g of diet), and 
a methionine supplemented diet (0.750 g/100 g of diet). These supplements 
were added to the diet of the rats after 4 days on the basal diet. During these 
initial four days, all of the rats lost weight. However, on the fifth day, rats began 
receiving the three supplements, and immediately showed an increase in weight, 
whereas the group of rats still receiving the basal diet continued to lose weight. 
The investigators concluded that homocysteine was an intermediate step in the 
pathway between methionine and cystine, as homocystine caused an increase in 
growth similar to that of both the methionine and cystine supplements. 
Finally, Finkelstein and Mudd provided the last piece of the puzzle, in 
1967. In a series of experiments designed to determine the enzymatic basis for 
the methionine-sparing effect of cystine and cysteine, they specifically studied the 
effect of cystine on cystathionine synthase. As it was already known that 
homocysteine had the potential to be recycled to methionine or be used in the 
synthesis of cysteine, investigators had focused on the regulation of the reaction 
that formed cystathionine. They examined cystathionine p-synthase activity in 
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young rats (125-150g) fed diets containing a basal level of methionine (2.5 g/kg) 
with supplements of methionine (8.0 g/kg) or cystine (7.68 g/kg). After 7 days on 
these diets, the rats on the cystine supplemented diet showed a 40% reduction in 
the activity of hepatic cystathionine ~-synthase compared with those on the basal 
diet or the methionine-supplemented diet. 
While the studies outlined above used laboratory rats as test subjects, 
experiments have also been performed to determine whether these results are, in 
fact, also relevant to human dietary needs. In 1955, Rose and Wixom employed 
nitrogen balance to examine the amino acid requirements of the human diet. 
They found that cystine could replace up to 89% of the methionine requirement in 
the diet of human males. In this experiment, the methionine requirement was 
determined for each subject to be approximately 1.0 g/d. The subjects were then 
fed a diet containing 0.8 g/d of methionine and 0.81 g/d of cystine. The level of 
methionine was then decreased until it reached 0.1 g/d of methionine. Below 
this, the nitrogen balance became negative; thus, an abundant cystine intake 
could replace up to almost 90% of methionine requirements in humans. 
Since 1955, many advances have been made in measuring amino acid 
metabolism in the body with perhaps the greatest contribution to this field being 
the use of tracers. In 1997, Raguso et a/ examined the methionine-sparing in 
humans with the addition of cystine to the diet by administering [1 -13C;methyi-
2H3]methionine and eH2]cystine. Groups of 6 healthy, young males were fed one 
of three diets: the first diet contained high methionine (13.0 mg/kg per day), but 
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no cystine; the second contained low methionine (6.5 mg/kg per day); and the 
final diet had low methionine (6.5 mg/kg per day), but was supplemented with 
cystine (5.6 mg/kg per day). This methodology allowed the investigators to 
determine a variety of flux measurements throughout the methionine metabolic 
pathways. The investigators found that there was no change in flux through the 
transsulfuration pathway when cystine replaced 60% of the methionine 
requirement; therefore, they concluded that no evidence for the cysteine sparing 
effect of methionine in humans was found . Using the same methodology, this 
same research group found similar results once again several years later 
(Ragusa eta/, 2000). 
The result of the above experiment was disputed recently by an 
investigation using another technique - indicator amino acid oxidation. In this 
technique, it is assumed that all amino acids enter a hypothetical pool - the only 
ways into the pool is via ingestion and protein degradation, while the only ways 
out are through amino acid catabolism and protein synthesis. The rate of entry 
into and out of the amino acid pool through protein degradation and synthesis are 
assumed to cancel each other out, thereby leaving the rate of ingestion 
equivalent to the rate of amino acid catabolism. Once an amino acid becomes 
deficient, all other amino acids that are still present in excess are catabolized. 
Therefore, it is possible to determine the concentrations at which a particular 
essential amino acid becomes deficient by examining the catabolism of an 
indicator amino acid. The purpose of this experiment by Di Buono eta/ (2001) 
was to determine new requirements for sulfur amino acids in the diet by using [1-
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13C]phenylalanine as the indicator amino acid. In this study, subjects received 0, 
2.5, 5.0, 7.5, 1 0.0, or 13.5 mg/kg per day of dietary methionine, while dietary 
cystine levels were consistently at 21 mg/kg per day. In the presence of this level 
of cystine in the diet, it was found that the minimum requirements for methionine 
in the diet dropped to 4.5 mg/kg per day with a safe limit of 10.1 mg/kg per day, a 
full 64% difference between methionine requirements without supplementary 
cystine. Therefore, it can be concluded, that cysteine does have a sparing effect 
on methionine requirements in humans. The reason that no methionine-sparing 
is found in previous studies that examined this effect in humans using tracer 
amino acids is most likely due to an insufficient amount of methionine in the diet. 
More current studies now focus on the molecular basis for regulation of 
cystathionine synthase, as researchers in Japan have discovered an increase in 
cystathionine synthase mRNA in rats fed diets low in cystine (Yamamoto eta/, 
1995). These studies have focused on six different diets, which can be broken 
down into two different groupings. The first three diets are supplemented with a 
high level of methionine (1 .0% of the diet) with no cystine, low cystine (0.75% of 
the diet), or high cystine (2.0% of the diet). The second grouping consisted of 
diets containing low methionine levels (0.25% of the diet) with no cystine, low 
cystine (0.75%), or high cystine (2.0%). The addition of either low cystine or high 
cystine to the low methionine diet caused significant decreases in the activity of 
cystathionine p-synthase. The addition of cystine to the high methionine diet did 
not cause significant differences in activity. The novel result from this study was 
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that changes in cystathionine ~-synthase mRNA levels paralleled those in 
enzyme activity. The author's concluded that the decrease in cystathionine ~­
synthase activity caused by the addition of cysteine to the diet was mainly the 
result of alterations in its mRNA levels. It should be noted that this effect was 
reduced with age. 
1.5 Objectives of Investigation and Specific Hypotheses 
Despite the growing amount of research on homocysteine metabolism and 
the associated sparing effect of methionine by cysteine supplementation in the 
diet, many questions still remain concerning the mechanisms involved. With this 
in mind, we have completed a series of experiments with the following questions: 
1. Can the manipulation of methionine and cysteine concentrations in 
incubations of isolated hepatocytes mimic the methionine-sparing 
effect? 
2. What are potential mechanisms by which methionine can be spared 
in both adult and young rats? 
3. What is the effect of excess dietary methionine on the metabolism of 
methionine in both young and adult rats? 
The specific hypotheses were: 
1. that the sparing effect of cysteine on methionine metabolism will not be 
evident in short term incubations with hepatocytes 
2. that the sparing effect can be explained by a combination of changes in 
gene expression and in the concentrations of allosteric effectors. 
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Chapter 2 - Materials and Methods 
2.1 Experimental Design 
In experiment 1, hepatocytes were incubated with varying concentrations 
of 1-14C-methionine and cysteine to determine any acute effects of sulfur amino 
acids on the transsulfuration flux, and if these variations could mimic the 
methionine-sparing effect. 
In experiment 2, purified amino acid diets were fed to adult rats in order to 
determine the effect that cystine in the diet would have on the methionine-sparing 
effect in animals fed a high methionine diet. Additionally, diets were also 
prepared to examine the effect of additional methionine on methionine 
metabolism. Experiment 3 was similar to experiment 2, except that it employed 
young rats. 
Finally, experiment 4 examined the effects of S-Adenosylmethionine on 
the kinetics of some of the regulatory enzymes of methionine metabolism. 
2.2 Animals 
In the first and fourth experiments, 4 Sprague-Dawley rats were used, 
each of which ranged, in weight, from 250 to 275g. Experiment 2 and 3 each 
required 16 Sprague-Dawley rats; however, the weight range for experiment 2 
was limited to 250-275 g, while the weight range for experiment 3 was 50-75g. 
The animals of experiment 4 were also Sprague-Dawley rats, and weighed 
between 250-275 g. All rats were obtained from the Memorial University of 
Newfoundland Vivarium. All protocols were approved by the Institutional Animal 
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Care Committee and adhered to the guidelines of the Canadian Council of 
Animal Care. 
In experiments 2 and 3, the animals were randomly separated into four 
separate groups and assigned to different diets. All animals in these two 
experiments were housed in individual cages throughout the experiment. 
2.3 Diet Composition 
In both experiment two and experiment three, four separate diets were 
used. The basic composition of each diet can be seen in Table 2.1. Each diet 
differed in their amino acid composition , with the first diet containing deficient 
levels of sulfur amino acids (Low SAA), the second diet containing a methionine 
supplement (High Met), the third diet containing a cystine supplement (High Cys), 
and the final diet consisting of both a methionine supplement and a cystine 
supplement (High M+C). 
All the diet components, as well as the amino acid composition, of each of 
the four diets were based on the work of Rogers and Harper (1965) and 
Newberne (1969). A crystalline amino acid mixture was used in place of casein 
in order to control the amounts of individual amino acids. A basal amino acid 
mixture was used that contained all amino acids at a level designed to optimize 
growth, with the exception of the SAA, which were added according to the diet 
group. A supplement with alanine was used to ensure the four diets were close 
to isonitrogenous. The amino acid components of the diets can be seen in Table 
2.2. The amounts of methionine and cystine added to the diets were equivalent 
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Table 2.1: Basic Composition of All Experimental Diets 
Diet Components Amount (g/kg diet) 
Cornstarch 369.572 
Amino Acids (Crystalline Mixture) 232.920 
Dextrinized Cornstarch 150.000 
Sucrose 100.000 
Soybean Oil 50.000 
Fiber 50.000 
Mineral Mix 35.000 
Vitamin Mix 10.000 
Choline Bitartrate 2.500 
Tertiary-butyl Hydroquinone 0.008 
TOTAL 1,000.000 
33 
Table 2.2: The Amino Acid Composition of the Diets 
ino Acids 
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in terms of sulfur content, and were based on diets developed by 
Finkelstein and Mudd (1967). 
Once the dry components of the diet had been adequately mixed, an 
equivalent amount of boiling 3% agar gel solution was added slowly, with heating 
(Newberne, 1969). Once the solution was completely added, the diet was 
thoroughly mixed into a slurry and left to cool for several minutes. The diet was 
then placed in an airtight container, and refrigerated until use. 
The animals were first fed an acclimatization diet over a period of three 
days. This acclimatization diet consisted of chow ground into a powder, and then 
dissolved in boiling agar to create a gel as described above. After the 
acclimatization period, the rats received their respective gel diet for a period of 
seven days. During this time, each rat was weighed once per day. Food intake 
was determined by measuring the amount of food given and what was left over 
each day. 
2.4 Liver Extraction 
On the day of sacrifice, each rat was anaesthetized with 65 mg/kg sodium 
pentobarbital. Approximately 2-3 ml of blood was drawn from the aorta into a 
heparinized syringe. A small piece of liver (approximately 0.5 g) was rapidly 
removed and homogenized in guanidium thiocyanate buffer for mRNA analysis, 
while a larger piece of liver (approximately 5 g) was homogenized in 50 mM 
Potassium Phosphate buffer (pH of 7.0) for enzyme assays. The remaining liver 
was removed and freeze-clamped using aluminum tongs pre-cooled in liquid 
nitrogen, and then stored at -80° C until analysis. 
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The blood was centrifuged at 10,000 g for 5 minutes in 1.5ml Eppendorf 
tubes. The plasma was removed and frozen until required. The liver portions 
used for fresh enzyme assays were diluted to 1:5 liver: potassium phosphate 
buffer, and then homogenized with a Polytron homogenizer (Brinkman 
Instruments, Toronto, Canada) for 20 seconds at an output of 50%. 
Homogenates were centrifuged at 10,000 g at 4° C for 30 minutes, and the 
supernatant was retained . 
2.5 Enzyme Assays 
MAT, CBS, CGL, BHMT, and MS were all assayed using fresh liver 
samples. The other assays could be performed on frozen liver samples. All 
enzyme assays were shown to be linear with protein concentration and 
incubation time under the conditions of our assays. 
2.5.1 Methionine Adenosyltransferase 
Methionine adenosyltransferase activity was determined using the 
methodology of Mudd et at (1965) and Duce et at (1988), and involves the 
production and measurement of 1-14C-S-Adenosylmethionine from 1-14C-
methionine. 1 mg of liver homogenate protein was added to an incubation 
medium of 100 mM Tris HCI (pH 7.8), 200 mM KCI, 10 mM MgCI2, 1 mM DTI, 5 
mM ATP, 1 mM benzamidine, and 0.1% P->-mercaptoethanol with a volume of 230 
IJI. The reaction was incubated at 37° C for 30 minutes upon the addition of 20 IJI 
of 62.5 mM 1-14C-methionine, in a final volume of 250 IJL, with a final 
concentration of 5 IJM of methionine. The reaction was stopped after the 30 
minute incubation with the addition of 750 IJL of ice cold H20. From this stopped 
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reaction mixture, 700 IJL was added to a column (0.9 x 2.0 em) of Dowex 50-X4 
(NH4 +) to separate the labelled SAM from the methionine. The column was 
washed with 20 ml of H20, and the SAM was eluted with the addition of 6 ml of 
3 M NH40H. 10 ml of Scintiverse was added, and the radioactivity of the sample 
was determined in a scintillation counter. Protein and time curves can be seen in 
Figure 2.1 . 
2.5.2 Glycine N-Methyltransferase 
Glycine N-methyltransferase was assayed by means of a modification of 
the method of Cook and Wagner (1984) which measured the production of 3H-
sarcosine from [methyi-3H]-S-adenosylmethionine. Frozen liver samples were 
homogenized in 50 mM potassium phosphate buffer (pH 7.0), and then diluted to 
a protein concentration of 0.075 mg per assay. 60 IJL of this protein homogenate 
was added to 100 j..JL of incubation medium, which consisted of 100 mM Tris HCI 
(pH 9.0), 2 mM glycine, and 5 mM OTT. To start the reaction, 60 j..JL of 1 mM 
[methyi-3H]-S-adenosylmethionine (with a final concentration of 0.3 mM) was 
added to bring the final volume up to 200 j..Jl. This mixture was incubated for 15 
minutes at 25° C, at which point the reaction was stopped with the addition of 100 
j..JL of 10% TCA. 500 IJL of 0.1 M acetic acid-washed charcoal suspension 
containing 950 mg of charcoal was added to each sample to absorb the 
remaining SAM, and was immediately vortexed. Samples were allowed to stand 
for 15 minutes, after which they were centrifuged at 3,200 g for 10 minutes. 500 
j..JL .of the supernatant was added to 10 ml of Scintiverse, for scintillation 
counting. Linearity for protein and time can be seen in Figure 2.2. 
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Figure 2.1: The production of S-adenolsylmethionine by hepatic 
methionine adenosyltransferase as a function of cytosolic protein 
concentration and incubation time. The time period used during the protein 
concentration studies was 30 minutes, while the time curve was determined using 
a protein concentration of 1.0 mg. 
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Figure 2.2: The production of 3H-sarcosine by glycine N-methyltransferase 
as a function of hepatic protein concentration and incubation time. The 
incubation period used during the protein study was 30 minutes, while the protein 
concentration used in the time determination was 0.075 mg. 
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2.5.3 Cystathionine 13-Synthase 
CBS was measured via a variation of the method of Miller et a/ (1994), 
which measures the production of 1-14C-cystathionine from 1-14C-serine. 3.0 mg 
of protein were incubated in a reaction mixture containing 187.5 mM Tris HCI, 
3.125 mM EDTA, 0.214 mM L-cystathionine, 62.5 mM homocysteine, 0.475 mM 
SAM, 3.125 mM propargylglycine, and 0.625 mM pyridoxal 5-phosphate. The 
reaction was started with the addition of 50 f..JL of 300 mM 1-14C-serine for a total 
reaction volume of 0.6 ml. The incubation continued for 1 hr. at 37°C, when it 
was stopped with the addition of 300 f..JL of ice cold 15% TCA. The samples were 
centrifuged at about 14,000 g for five minutes, after which, 0.5 ml of supernatant 
was added to columns (0.9 x 2.0 em) containing Dowex 50w-x4 resin (200-400 
mesh, H+ form) . These columns were washed with 8 ml of water, 24 ml of 1M 
HCI, and a further 16 ml of water. Finally, the radiolabelled cystathionine was 
collected from each column with 5 ml of 3M NH40H. 1 ml of the eluted solution 
was added to 10 ml of scintiverse, and the radioactivity was counted in a 
scintillation counter. The curves depicting cystathionine 13-synthase activity as a 
function of time and protein are shown in Figure 2.3. 
2.5.4 Cystathionine y-Lyase 
The method used to determine CGL activity was based on that of Stipanuk 
eta/ (1979). Cytosolic protein (1.5 mg) was added to a 2 ml cocktail in a cuvette 
containing 0.125 mM potassium phosphate, 0.32 mM pyridoxal 5-phosphate, 
0.32 mM 13-NADH, 4.0 mM of L-cystathionine, and approximately 1.5 units of 
lactate dehydrogenase (LDH) at 37° C in a thermostatted spectrophotometer. 
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Figure 2.3: The production of cystathionine from hepatic cystathionine J3-
synthase as a function of protein concentration and incubation time. The 
incubation period used during the protein determination was 60 minutes, whereas 
the protein concentration used during the time determination was 3.0 mg. 
43 
5000 
-cu tn 
c::: ~ 4000 
·- 0 § E 
·- c::: ~- 3000 
ns c::: 
~o 
tn--~0 2000 
I ::J (.)"'C 
...,. 0 
or- c. 1000 
• 
0~--~----~--~--~----~--~--~ 
5000 
-cu tn 
c::: cu 4000 
·c:o 
-~ E ~ .s 3000 
S-c 
tn cu 
~ g 2000 
'"'C Oo 
...,. '-
or- a. 1000 
0 1 2 3 4 5 6 7 
Protein (mg) 
• 
• 
o~--~~--~----~----~--~----~ 
0 25 50 75 100 125 150 
Time (min) 
44 
One of the products of the CGL reaction is a-ketobutyrate, which can act as a 
substrate for LDH. The decrease in absorbance at 360 nm measures the 
oxidation of NADH, and is used to determine the activity of CGL. Enzyme activity 
was determined from the linear portions of the graph. The dependence of CGL 
on protein concentration can be seen in Figure 2.4. 
2.5.5 Methylenetetrahydrofolate Reductase 
MTHFR was measured according to the method of Engbersen et a/ 
(1995). 0.1 mg of frozen liver homogenate protein was incubated at 37°C with 
400 !JL of reaction cocktail , which consisted of 50 mM potassium phosphate 
buffer (pH 6.8), 11 .5 mM ascorbic acid , 1.15 mM EDTA, 54 !JM FAD, and 20 !JM 
[ 14C-CH3]methyltetrahydrofolate. 100 !JL of menadione was added to bring the 
total reaction volume to 600 !JL and begin the reaction which was at 37°C for 20 
minutes, in the dark. After 20 minutes, the reaction was stopped by the addition 
of a combination of 100 !JL of 3 M potassium acetate (pH 4.5), 200 !JL of 
dimedone dissolved in ethanol:water (1 :1 ), and 10 IJL of 1.0 M formaldehyde. 
The samples were immediately heated in a 95°C water bath for fifteen minutes, 
followed by cooling in an ice bath for ten minutes. After removal from the ice 
bath, 3 ml of toluene was added to each of the samples, which were all 
centrifuged at low speed for approximately 5 minutes. 2 ml of the toluene phase 
was removed and added to 10 ml of Scintiverse for scintillation counting. The 
dependence of MTHFR activity on protein concentration and incubation time can 
be seen in Figure 2.5. 
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Figure 2.4: The dependence of cystathionine y-lyase activity on protein 
concentration. The activity was evaluated over 10 minutes. 
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Figure 2.5: The activity of methylenetetrahydrofolate reductase as a 
function of protein concentration and incubation time. The protein 
concentration used during the time determination was 0.15 mg, whereas the 
incubation period used while protein concentration was examined was 15 
minutes. 
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2.5.6 Methionine Synthase 
Methionine Synthase was assayed according to the method of Kolbin eta/ 
(1981 ). The cytosolic protein (1 00 i.JL at 1.0 mg/assay) was added to a reaction 
mixture (1 00 j.JL) containing 87.5 mM potassium phosphate buffer (pH 7.5), 58 
mM DTI, 14 mM 8-mercaptoethanol , 20 i.JL of cyanocolbalamin , 15 mM 
homocysteine, 0.5 mM S-adenosylr:nethionine, and 1 mM of [5-
14C]methyltetrahydrofolate (0.25 j.JCi) in a total of 200 j.JL reaction volume. This 
reaction mixture was incubated in the dark at 37°C for 30 minutes, and was 
stopped with the addition of 500 i.JL of ice-cold water. After stopping the reaction, 
the samples were placed on ice until ready to be added onto a column (0.9 x 2.0 
em) containing Bio-Rad washed with 1.5 ml of water and the effluent was 
collected. This 1.5 ml of effluent was then added to 10 ml of Scintiverse and the 
radioactivity determined. The effects of protein and incubation time can be seen 
in Figure 2.6. 
2.5.7 Betaine:Homocysteine Methyltransferase 
BHMT was assayed by a modification of the method of Wang eta/ (1991 ). 
Cytosolic protein (1 00 j.JL of protein at 0.3 mg/assay) was added to a reaction 
mixture containing 125 mM Tris HCI, 25 mM homocysteine, and 10 mM of 1-14C-
betaine, all of which were incubated in at a temperature of 37°C for 1 hour with a 
total volume of 500 j.JL. The reaction was stopped with the addition of 2.5 ml of 
ice-cold water and the samples immediately placed in an ice bath. 2 ml of the 
stopped 
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Figure 2.6: The effect of protein concentration and incubation time on 
methionine production via hepatic methionine synthase. The protein 
concentration during the incubation investigation was 1.0 mg, while the 
incubation period during the protein concentration determination was 30 minutes. 
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reaction was added to columns contain ing Dowex 1-X4 resin (OH-; 200-400 
mesh). The columns were then washed with 15 ml of water and eluted with 3 
ml of 1.5 M HCI. The elutant was added to 10 ml of Scintiverse. The effect of 
protein concentration and time can be seen in Figure 2.7. 
2.5.8 Choline Dehydrogenase 
Choline dehydrogenase. activity was assayed by Grossman and Hebert's 
(1989) modification of the method of Haubrich and Gerber (1981 ). Frozen liver 
homogenate was diluted to 1.0 mg protein I ml, and incubated at a temperature 
of 3rc in a cocktail of potassium phosphate (pH 7.0, 0.5 M), 0.7 mM choline, 1.0 
mM phenazine methosulfate and 1.0 mM CaCI2. After a ten minute incubation, 
the samples were placed on ice after the addition of 1 N NaOH and 30% H20 2. 
The samples were then incubated for another hour at room temperature The 
figures depicting the effect of protein concentration and incubation time on CHDH 
activity can be seen in Figure 2.8. 
2.4.9 SAM-dependent Enzyme Assays 
The fourth experiment focused on the effects of SAM on allosteric control 
of a number of enzymes. The enzymes examined were CBS, BHMT, and 
MTHFR; the first two assays required fresh liver homogenate, while the MTHFR 
assay used frozen liver samples. 
All enzyme assays were completed as above with some modifications. 
The first modification was that after each sample had been homogenized and 
diluted to a 1:4 liver: homogenization buffer ratio, the samples were run through a 
PD-1 0 column. This column retains all small molecules and salts, allowing the 
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Figure 2. 7: The effect of protein concentration and incubation time on 
methionine production by betaine:homocysteine methyltransferase. The 
incubation period during protein concentration trials was 1 hour, while the protein 
concentration during the incubation period trials was 0.3 mg. 
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Figure 2.8: The effect of protein concentration and incubation period on 
choline dehydrogenase activity. During the protein concentration 
determination, the incubation period was 10 minutes, whereas the protein 
concentration was 1.0 mg during the incubation period determination. 
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homogenate to become free of endogenous SAM and SAH. Approximately 20 
ml of water were run through the column before 2.5 ml of each liver sample was 
placed on a column. The 2.5 ml of SAM-free homogenate was eluted by the 
addition of an additional 5.0 ml of water. A fraction of the liver homogenate was 
saved for SAM and SAH analysis. 
2.6 Substrate Concentration Determination 
2.6.1 Amino Acid Determination 
Both plasma and liver amino acids were analyzed using the Department of 
Biochemistry Amino Acid Facility. 10% sulfosalicylic acid was added to plasma 
samples, following which the samples were allowed to cool on ice for 30 minutes. 
After the cooling period , 0.025 ml of an internal standard (AEC) and 0.275 ml of 
lithium citrate buffer (pH 2.2) were added to the samples. The samples were 
then spun at 11 ,000 rpm for 5 minutes, and the supernatant was saved for 
analysis. 
For liver samples, 4 ml of ice cold 6% HCI04 was added to 1 g of finely 
ground, frozen liver and homogenized at 4°C. The liver sample was spun at 
17,000 g for 20 minutes, and the supernatant saved. 0.020 ml of dilute universal 
indicator and 0.1 ml K2C03 (50%) were added to each sample, and the pHs of 
the samples neutralized with the addition of KOH . After centrifugation to remove 
the precipitated KCI04 , the supernatants were then frozen . When samples were 
ready to be analyzed, the pH was adjusted to 2.2 using concentrated HCI. 
Both the liver and the plasma samples were analyzed in the MUN 
Biochemistry Amino Acid Facility, using a Beckman 121 MB Amino Acid Analyzer 
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with a Benson 0-X, 0.25 cation Xchange Resin and a single column, three buffer 
lithium method as per Beckman 121MB-TB-017 application notes. The results 
were then quantified with a Hewlett Packard Computing Integrator Model 3395A. 
2.6.2 SAM and SAH Determination 
Approximately 1 g of frozen liver sample was homogenized in 5 ml of ice 
cold 8% TCA, and then centrifuged at 12,500 g. The supernatant was collected 
and analyzed via HPLC using a VYDAC column (#2187P54) that was 
equilibrated with 96% 50 mM NaH2P04 , 10 mM heptane sulfonic acid (which was 
adjusted to a pH of 3.2 with concentrated sulphuric acid) and 4% acetonitrile. A 
20 minute linear acetonitrile gradient (4% to 20%) was used to separate the SAM 
and the SAH. Peaks were determined at 258 nm with a UV detector; these 
peaks were then quantified with a 3390A Hewlett Packard Integrator. The 
concentrations of SAM and SAH were determined by reference to a standard 
curve (Figure 2.9). 
Our lab modified the HPLC method of Vester and Rasmussen (1991) for 
determining the concentrations of plasma and liver homocysteine, cysteine and 
glutathione. 20 ~L of 10% tri-n-butyl-phosphine in dimethylformamide was added 
to 150 ~L of either plasma or frozen liver samples. After the thiols were allowed 
to become reduced during a thirty minute period at 4° C, the samples were 
deproteinized by the addition of 125 ~L of 0.6 M perchloric acid. 50 ~L of 0.2 mM 
8-aminonaphtalene-1,3,6-trisulfonic acid was added as a standard , and the tubes 
were centrifuged at 14,000 g for 5 minutes at 4°C. After the centrifugation, 
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Figure 2.9: Standard curve for S-adenosylmethionine and S-
adenosylhomocysteine on HPLC with UV detection. 
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100 1-JL of supernatant was added to an Eppendorf tube containing 200 1-JL of 2 M 
potassium borate (pH 10.5) containing 5 mM EDTA and 100 1-JL of ammonium 7-
flurobenzo-2-oxo-1,3-diazole-4-sulphonate solution (1.0 g/1 in 2 M potassium 
borate, pH 9.5). After a 60 minute incubation period at 60°C and a cooling period 
of fifteen minutes in an ice bath, 20 1-JL where injected into an HPLC. 
2.6.3 Homocysteine and Other Thiol Determination 
All samples were analyzed using a Shimadzu system (Pump GT-104, 
SCL-1 OA Controller, Sl L-1 OA Auto Injector, LC-1 OAD Liquid Chormatograph, RF-
535 Fluorescence Monitor) equipped with a Phase Separations Hypersil C 18-
0DS analytical column (4.6 x 150 mm). The fluorescence intensities were 
measure with excitation at 385 nm and emission at 515 nm. The detection signal 
was recorded and the peaks were quantified using a Man-Tech Shimadzu CR501 
Chromatopac integrator. Figure 2.10 is an example of a typical plasma 
chromatogram. 
2.7 Transsulfuration Flux Determination 
2.7.1 Isolation of Primary Hepatocytes 
Primary hepatocytes were prepared us1ng the method of Berry et a/ 
(1991 ). Rats were anesthetized with 65 mg/kg sodium pentobarbital, and then 
injected with 100 1-JL of heparin (1 000 units/ml) through the femoral vein. A 
cannula was inserted into the portal vein, and perfusion was quickly begun with 
500 ml of calcium-free Krebs-Henseleit medium (144 mM Na+, 6 mM K+, 1.2 mM 
Mg2+, 126 mM cr, 1.2 mM H2Po4-, 1.2 mM sol·, 25 mM HC03-) containing 
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Figure 2.10: A sample chromatogram of plasma analysis for homocysteine, 
cysteine, cys-gly, and glutathione. The peak for cysteine appears at 3.1 
minutes; the peak for homocysteine appears at 4.2 minutes; the peak for cys-gly 
appears at 5.5 minutes; and the peak for glutathione appears at 7.3 minutes. 
The standard, 8-aminonaphthalene-1 ,3,6-trisulfonic acid , appears at 1.5 minutes. 
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2 mM EGTA, 20 mM glucose, 2.1 mM lactate, and 0.3 mM pyruvate (pH 7.4) and 
gassed, for 20 minutes, with 19:1 0 2/C02. The perfusion flow rate was 40 
mllmin. Following a 12-minute flow-through period, the medium was switched to 
500 ml Krebs-Henseleit solution containing 1.3 mM Ca2+, 20 mM glucose, 2.1 
mM lactate, and 0.3 mM pyruvate, which was also gassed with 0 2/C02 for 20 
minutes. 
A cannula was inserted through the right atrium and into the inferior vena 
cava. Krebs-Henseleit medium supplemented with 0.25% BSA and collagenase 
(50 mg/1 00 ml) was then recirculated through the liver. To begin the flow 
through the liver, the inferior vena cava was cut below the kidney. The 
recirculation of perfusate continued until the liver became soft (approximately 20 
minutes), at which point the liver was transferred to a petri dish containing 
collagenase medium and massaged gently to liberate cells. The resulting 
suspension was incubated at 37°C for 1 0 minutes in a shaking water bath under 
constant gassing with 0 2/C02. Following filtration through a cheesecloth , the 
cells were centrifuged at 600 rpm for 2 minutes. The cells were resuspended in 
Krebs-Henseleit solution containing calcium, and the filtration was repeated . 
After a final wash with Krebs-Henseleit medium containing 2.5% BSA, the cell 
pellet was resuspended in this medium. Hepatocytes were quantified by drying 
3.0 ml of resuspended cells and 3.0 ml of 2.5% BSA Krebs-Henseleit medium in 
tared vessels at 50 degrees for 24 hours. The difference in the weights 
represented the dry weight of the cells. Cell viability was determined by means of 
0.1% trypan blue exclusion. 
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2. 7.2 14C02 recovery from isolated hepatocytes 
The determination of the flux through the transsulfuration pathway takes 
advantage of the fact that the CGL reaction produces a-ketobutyrate. Incubation 
of the primary hepatocytes with [1 -14C]methionine will result in the production of 
[1-14C]a-ketobutyrate, which can act as a substrate for pyruvate dehydrogenase, 
liberating 14C02 in the process. [1-14C)a-ketobutyrate is treated with hydrogen 
peroxide, which decarboxylates it. After determining the amount of 14C02 that 
was released, the sum of the two values results in a measure of the flux through 
transsulfuration, as can be seen in Figure 2.11 . 
The primary hepatocytes were incubated with 1 mM L-[1 -14C)methionine 
(American Radiolabeled Chemicals, Inc., St. Louis, MO) for 30 minutes. At the 
end of the incubation period, Incubations were terminated with the injection of 0.3 
ml of 30% (wUvol) perchloric acid via a syringe through rubber septa with 
suspended centre wells containing NCS tissue solubilizer, and the 14C02 was 
collected for one hour. Each of the centerwells was added to scintillation vials 
containing Omnifluor scintillation fluid . New centerwells were added to each flask 
and 0.3 ml of 30% (wt/vol) hydrogen peroxide was added to the samples in the 
same way as the perchloric acid . Once again, the 14C02 was collected for one 
hour, and the centerwells added to Omnifluor scintillation fluid-containing 
scintillation vials. The radioactivity was then determined using a scintillation 
counter. 
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Figure 2.11: Transsulfuration flux determination in isolated hepatocytes. 
The radiolabelled carbon atom proceeds from the transmethylation pathway into 
the transsulfuration pathway, where the action of CBS removes the label in the 
form of a-ketobutyrate. Some of the a-ketobutyrate does move into the 
mitochondria, where it acts as a substrate for pyruvate dehydrogenase (PDH), 
which produces C02. Any unreacted 1-14C-a-ketobutyrate can be decarboxylated 
with H202. 
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2.8 RNA Isolation and Northern Blot Analysis 
Total RNA was isolated by the rapid guanidinium isothiocyanate method 
as described by Chomczynski and Sacchi (1987). RNA was denatured in 
formamide (50%), formaldehyde (6.5%) sample buffer at 65°C for 15 minutes. 
The RNA was then separated on formaldehyde (1.8%), agarose (0.8%), and 
transferred to a nylon (S & S Nytran) membrane (Schleicher & Schuell). RNA 
was fixed by UV cross-linking . The membranes were prehybridized and then 
hybridized with a eDNA probe specific for rat CBS (2.3 kb EcoRI fragment of rat 
CBS eDNA, which was random-primer-labelled with [a-32P]dCTP (3000 Ci/mmol; 
PerkinEimer Life Sciences) using the MegaPrime labelling kit (Amersham 
Biosciences) according to the manufacturer's instructions). The membranes 
were stripped and hybridized with a random primer radiolabelled 13-actin eDNA 
probe (CLONTECH Laboratories, Palo Alto, CA) and washed at high stringency 
(final wash, 0.1% SSC, 0.1% SDS at 53°C). Autoradiography was carried out by 
exposure of the blot to Kodak XAR or Biomax film. Autoradiographs were 
scanned on Chemi-lmager 4000, and RNA levels were quantitated with Alpha 
Ease software (Alpha lnnotech Corporation, San Leandro, CA). 
2.9 Statistical Analysis 
All results are expressed as mean .±. standard deviation. Statistical 
analysis between means was determined by means of a one-way ANOVA 
followed by a Neuman-Keul 's multiple means test. In each analysis, a P value < 
0.05 indicated a significant difference. 
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Chapter 3: Results and Discussion 
3.1 Transsulfuration Flux in Hepatocytes- Effect of Cysteine 
3.1.1 Background 
It is known that the composition of the diet affects the metabolism of 
methionine in mammals. One of the most important of these dietary effects is the 
methionine-sparing effect, whereby the requirements for dietary methionine are 
reduced by cysteine. While this effect is well known in vivo, the effect of acute 
addition of cysteine to incubated hepatocytes has not been investigated . To 
examine this effect, hepatocytes from 4 Sprague-Dawley rats were incubated 
with different concentrations of 1-14C-methionine and unlabelled cysteine, and the 
transsulfuration flux determined. Both radiolabelled a-ketobutyrate and carbon 
dioxide were measured as a measure of total transsulfuration flux (Stead et a/, 
2001 ). If the methionine-sparing effect is evident in hepatocytes, we would see a 
decrease in the transsulfuration flux upon addition of cysteine. 
3.1.2 Results 
Two concentrations of methionine were used - 1. 0 mM 1-14C-methionine and 
0.1 mM 1-14C-methionine. For each of these groups,· hepatocytes were also 
incubated with and without 1.0 mM cysteine or with and without 0.1 mM cysteine. 
The recovered label was measured as nmol 14C/30 min incubation time/mg dry 
weight of the hepatocytes. As both 14C02 and 14C-a-ketobutyrate are 
components of transsulfuration flux, both of these are presented in Table 3.1. 
Table 3.1 shows that, at 1.0 mM methionine, the addition of cysteine, at 
either concentration , was without effect. At 0.1 mM methionine, however, the 
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addition of an unphysiologically high cysteine concentration (1.0 mM) results in a 
30% decrease in transsulfuration flux. 
Our results show that, at physiological concentrations of methionine and 
cysteine, no sparing effect is evident. This result suggests that the sparing effect 
in vivo does not occur by an acute mechanism. 
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1.67+0.12 1.23 + 0.36 
a-keto 0.98 + 0.29 0.59 + 0.07 
Total 1.82 + 0.33c 
Table 3.1: The effect of varying concentrations of methionine and cysteine on 
transsulfuration flux in isolated rat hepatocytes. The values are presented in 
terms of nmol/30 min/mg dry weight of hepatocytes. 
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3.2 The Effect of Varying Concentrations of Dietary Methionine and 
Cysteine on Hepatic Sulfur Amino Acid Metabolism in Adult Rats 
3.2.1 Background 
The sparing effect on methionine, an essential amino acid in mammals, by 
the addition of cysteine to the diet has been shown several times (Finkelstein, 
Martin & Harris, 1986; Finkelstein, Martin & Harris, 1988). To investigate this 
mechanism, we fed rats one of four different diets. The first diet contained only 
methionine as a sulfur amino acid , which was provided at an insufficient amount 
(Low SAA); the second diet contained a supplement of methionine (High 
Methionine); the third diet contained an insufficient amount of methionine with a 
supplement of cystine (High Cystine); while the fourth diet contained a 
supplement of both sulfur amino acids (High Methionine + Cystine). Rats were 
fed these diets ad libitum for one week, after which plasma and liver metabolites, 
as well as enzyme activities were determined. 
3.2.2 Results 
3.2.2.1 Body Weight 
Sprague-Dawley rats with an initial weight of approximately 250 g each 
were used. The rats were weighed every day. At the end of the feeding 
experiment, the Low SAA group had gained an average of 21 .75 g, whereas the 
High Methionine group, the High Cystine, and High Methionine + Cystine groups 
had all gained significantly more (mean of 47.00 g, 55.30 g, and 57.75 g 
respectively). Weight gain is presented in Figure 3.1. 
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Figure 3.1: The effect of varying dietary methionine and cystine on weight 
gain in adult Sprague-Dawley rats. Figure 3.1 a demonstrates the average 
weight gain in grams of each of the four diet groups over the 7 day experiment. 
Figure 3.1 b displays daily weight gain in grams of the rats over the seven-day 
feeding period. Different subscripts indicate significantly different results . 
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3.2.2.2 Transmethylation and Transsulfuration 
Table 3.2 shows that increased methionine intake, but not cystine intake, 
increased hepatic MAT activity. Table 3.3 shows that increased dietary 
methionine, not cystine, results in a massive increase in SAM levels. There were 
also very large increases in hepatic SAH levels. Together with the elevated 
hepatic methionine levels, these results indicate a very large increase in 
transmethylation. If this is so, the question arises: which transmethylation 
reaction(s) is (are) increased? The conventional wisdom is that the glycine-N-
methyltransferase reaction acts as an over-flow methylation reaction for the 
disposal of excess methionine. Evidence that this is occurring in this situation is 
provided in Tables 3.4 and 3.5, where a substantial increase in both plasma and 
liver sarcosine is evident in the animals fed the high methionine diets. Increased 
f.lux through the transmethylation pathway will generate increased quantities of 
homocysteine. Unfortunately, we were unable to measure the hepatic content of 
this amino acid but the massively increased plasma tHey provides evidence for 
the increased synthesis of this amino acid. Increased catabolism of methionine 
occurs via increased flux through the transsulfuration pathway. The ingestion of 
the high methionine diets did not result in increased CBS activity when measured 
in vitro; however, the elevated SAM levels would be expected to activate CBS 
and promote increased transsulfuration . Evidence that this has actually occurred 
is provided by two observations - the increased plasma and liver levels of 
cystathionine and of 2-aminobutyrate, which is produced by the transamination of 
a-ketobutyrate (Table 3.2). 
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High High Assay Low SAA Methionine High Cystine Methionine+ Cystine 
MAT 
nmol/min/mg 3.50 ± 0.47 a 5.75 ± 0.30 b 3.00 ± 0.24 a 6.14 ± 0.39 b protein 
nmol/min/g 335.45 ± 38.9 539.02 + 292.28 + 556.88 + 
liver a 40.45 b 33.67 a 78.82b-
CBS 
nmollmin/mg 11.47 ± 0.81 11 .17 + 1.56 6.86 ± 1.21 12.82 ±1.52 protein 
nmol/min/g 1.11±0.14 1.05 ± 0.16 0.66 ±._0.10 1.12 ± 0.23 liver 
CGL 
nmol/min/mg 16.32 ± 2.11 a 27.83 ± 4.32 b 22.15±1 .53b 28.83 ± 1.23 b protein 
nmol/min/g 1578 ± 293.5 2598 + 306.6 2158 + 251.0 2600.1 + 
liver a li li 174.4 b 
BHMT 
nmol/min/mg 1.73±0.21a 1.07±_0.10b 1.92 + 0.28 a 1.80 ± 0.20 a protein 
nmollmin/g 167.00 ± 101.20 + 186.13 + 162.75 ± 
liver 23.87 a 14.03 b 17.19a 24.72 a 
MS 
nmol/min/mg 0.084 ± 0.008 0.089 ± 0.008 0.099 ± 0.002 0.102 ± 0.004 protein 
nmollmin/g 8.08 ± 0.43 8.33 ±1 .13 9.67 ± 0.45 9.22 ± 0.44 liver 
MTHFR 
nmol/min/mg 0.20 ± 0.02 0.21 ± 0.04 0.21 ± 0.03 0.20 ± 0.04 protein 
nmollmin/g 0.042 ± 0.009 0.043 ± 0.008 0.044 ± 0.007 0.042 ± 0.008 liver 
. . . Table 3.2: The Effect of Varying Dietary Sulfur Ammo Ac1d Concentrations 
on the Activity of Enzymes in the Methionine Metabolic Pathway in Adult 
Sprague-Dawley Rats. Data are presented in nmol/min/mg protein and 
nmol/min/g liver. Each superscript represents data that is significantly different 
from the other. 
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Metabolite Low SAA High High Cystine High 
Methionine Methionine+ 
Cystine 
Methionine 
Plasma (JJM) 53.9 .±. 4.4 a 478.6 + 166.7 52.6 .±. 4.5 a 488.3 + 150.9 
o o 
Liver (nmol/g) 30.7 .± 7.8 a 167.1 .±. 40.6 b 35.4 + 2.5 a 146.1 + 107.1 
o 
SAM (nmollg) 81 .5 + 3.4a 577.8 + 72.1° 80.0 + 10.0a 351.0 + 24.1c 
SAH (nmol/g) 6.8 + 0.9a 78.4 + 15.8° 7.0 + 1.6a 80.1+ 6.6° 
Total 
Homocysteine 
Plasma (JJM) 15.6 + 0.8 a 217.9 + 46.6 D 8.1 + 2.0 a 379.4 + 71.4 c 
Cystathionine 
Plasma (JJM) Trace a 8.3 + 1.4 D Trace a 15.4 + 3.1 c 
Liver (nmollg) 32.9 + 8.2 a 79.6 + 48.7 O 20.8 + 1.2 c 80.9 + 27.1 D 
Total Cysteine 
Plasma (JJM) 169.3 + 14.2 163.3 + 22.0 207.8 + 66.1 186.7 + 50.0 
Table 3.3: The Effect of Varying Dietary Sulfur Amino Acid Concentrations 
on Intermediates of Methionine Metabolism Substrates in Adult Male 
Sprague-Dawley Rats. 
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Table 3.4: The Effect of Varying Dietary Sulfur Amino Acids on Plasma 
Amino Acid Concentrations in Adult Male Sprague-Dawley Rats. All 
measurements are in j.JM . 
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Plasma High High 
Metabolite Low SAA Methionine High Cystine Methionine+ Cystine 
Taurme 92 9 + 7 7 301 3 + 24 5 I 310 6 + 53 9 I 369 1 + 89 1 I 
Urea 6943.5 ± 1004.3 21757.6 ± 26144.8 ± 105959.0 ± 16200.6 17116.8 56817.0 
Aspartic Acid 19.9 + 2.5 a 28.7 + 6.1 aD 27.8 + 3.5 aD 41.5 + 16.2 II 
Hydroxyproline 36.8 + 6.8 34.9 + 2.4 45.5 + 11.5 46.8 + 8.5 
Threonine 227.7 + 17.1 aD 194.5 + 17.5 II 268.6 + 41.6 ab 267.9 + 48.1 aD 
Serine 166.0 + 12.2 159.0 + 23.6 199.0 + 11.1 168.4 + 39.0 
Asparagine 89.0 + 11.2 79.7 + 18.7 120.2 + 20.2 118.2 + 41.8 
Glutamic Acid 206.2 +49.2 146.5 + 9.4 196.4 + 49.8 168.5 + 52.8 
Glutamine 436.5 + 49.7 a 401.7 + 45.6 a 333.9 + 13.5 II 447.7 + 48.0 a 
Sarcosine 2.7 + 2.3 a 16.3 + 8.7 D 2.3 + 1.5 a 18.5 + 5.0° 
Proline 148.4 + 18.3 152.2 + 10.6 168.8 + 16.3 176.5 + 28.2 
Glycine 443.1 + 53.4 a 310.1 + 81.8 II 521.6 + 54.2 a 526.0 + 124.4 a 
Alanine 654.3 + 76.7 670.6 + 123.1 725.6 + 84.6 722.9 + 148.6 
Citruline 54.2 + 6.2 a 71.2 + 8.0 D 52.8 + 8.3 a 85.9 + 5.2 c 
a-Ami no-n- 7.8 ±4.1 a 32.4 ± 12.4 b 5.4 ± 3.6 a 33.9 ± 6.7 b butyric Acid 
Valine 201.8 + 16.5 8 117.1 + 6.5 D 209.7 + 39.6 a 122.6 + 36.5 b 
Cystine Below detection Below detection Below detection 18.4 ± 7.4 b levels a levels a levels a 
Methionine 53.9 + 4.4 a 476.8 + 166.7 D 52.6 + 4.5 a 488.3 + 150.9 D 
Isoleucine 108.0 + 11.2 a 61.3 + 9.0 II 115.1 + 18.9 a 61.0 + 14.2 II 
Leucine 97.3 + 8.1 a 65.6 + 16.9 II 114.4 + 28.4 a 55.5 + 22.5 II 
Tyrosine 62.2 + 5.5 a 48.9 + 7.2 a 61.5 + 5.5 a 109.3 + 24.1 II 
Phenylalanine 69.4 + 3.5 a 53.5 + 1.7 D 61.7 + 8.3 ab 57.9 + 10.5 ab 
Tryptophan 107.7 + 5.5 a 92.4 + 9.0 aD 93.3 + 12.5 aD 78.7 + 12.7 D 
Ethanolamine 15.4 + 9.2 16.0 + 5.0 8.5 + 2.3 14.8 + 1.7 
Ammonia 125.3 + 7.2 a 105.7 + 5.8 II 104.6 + 5.2 D 107.1 + 7.0 11 
Hydroxy lysine 1.0 1.0 1.0 1.0 
Ornithine 71.4 + 9.1 a 80.6 + 18.3 a 83.9 + 15.9 a 113.7+ 8.2 11 
Lysine 442.5 + 92.7 515.4 + 73.5 532.5 + 99.2 622.6 + 101.7 
Histidine 35.3 + 7.1 a 44.6 + 2.9 II 49.4 + 5.4 II 53.1 + 6.4 II 
3-Methylhistidine 1.3 + 0.6 a 1.0 + 0.7 a 1.0 0 
Arginine 162.0 + 17.4 183.6 + 41.5 170.1 + 17.5 187. 1 + 63.0 
Cystathionine Tr~ce a 8.3 + 1.4 D Trace a 15.4 + 3.1 c 
Homocysteine Below detection Below detection Below detection 10.7 b levels a levels a levels a 
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Liver High High Low SAA High Cystine Methionine+ Metabolite Methionine Cystine 
Taurine 4505.3 ± 281.7 10137.7 + 10169.2 + 10791.4 ± a 5589.9 b 1159.5 b 964.8 b 
Urea 24655.9 ± 1554335.1 + 2056561.5 + 2705963 ± 11080.7 a 623944.6 b 167259.8 b 515397.4 c 
Aspartic Acid 2386.8 ± 413.7 3004.3 ± 2402.9 ± 1181.3 ± 1430.7 1478.0 1131.5 
Hydroxyproline Below detection Below detection Below detection Below detection levels levels levels levels 
Threonine 269.6 + 50.1a 143.1 + 40.4 b 226.5 + 32.0 a 223.4 + 49.6 a 
Serine 539.0 + 164.8 a 86.9 + 31.1 D 416.4 + 62.3 a 111.0 + 25.1 D 
Asparagine 81.1 + 27.4 44.2 + 20.2 74.5 + 20.3 73.2 + 34.9 
Glutamic Acid 2784.1 ± 690.8 854.6 ± 386.4 b 1442.4 + 135.2 873.4 ± 365.2 b a b 
Glutamine 4536.3 ± 839.7 3041.2 ± 3115.6±403.2 3201.4 ± 374.9 1821.9 
Sarcosine 24.2 + 21.6 a 87.0 + 51.8 ab 57.8 + 23.6 a 112.6 + 43.3 b 
Proline 646.2 + 244.8 193.4 + 178.3 583.5 + 317.8 632.4 + 159.8 
Glycine 4199.8 ± 732.0 ± 394.1 b 3128.6 ± 540.9 1273.4 + 152.3 1129.4 a c b 
Alanine 2993.1 ± 951. 1967.5 ± 2413.9 ± 266.7 2558.6 ± 352.7 1502.2 
Citruline 50.2 + 4.2 abC 22.0 + 14.4 aD 43.5 + 15.8 abC 66.2 + 22.9 ac 
a-Ami no-n- 12.9 ± 9.4 51.7 ± 43.3 11.1±5.4 43.3 ± 35.1 butyric Acid 
Valine 140.8 + 14.3 a 64.5 + 33.3 D 134.2 + 20.9 a 66.0 + 30.0 D 
Table J.Sa: The Effect of Varying Dietary Sulfur Amino Acid Concentrations 
on Hepatic Amino Acid Concentrations in Adult Male Sprague-Dawley Rats. 
All metabolites are expressed as j.Jmol/g wet weight. 
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Liver High High High Low SAA Methionine+ Metabolite Methionine Cysteine Cystine 
Cysteine Below 155.7 ± 138.2 a Below 257.7 ± 62.7 a detection levels detection levels 
Methionine 30.7 + 7.8 a 167.1 + 40.6 D 35.4 + 2.5 a 146.1 + 107.1 D 
Isoleucine 101.2 ± 23.6 a 39.0 ± 25.6 b 89.7 ± 14.3 a 59.1 ± 11.8 b 
Leucine 121.6 + 23.5 a 59.8 + 31.4 D 101.2 + 29.8 a 55.2 + 28.4 D 
Tyrosine 24.6 + 11.1 22.6 + 21.2 36.9 + 9.1 46.2 + 11.5 
Phenylalanine 61.6+16.1 63.5 + 30.3 47.6 + 8.2 65.3 + 18.1 
Tryptophan Below Below Below Below detection levels detection levels detection levels detection levels 
Ethanolamine 30.1 + 13.0 12.9 + 1.0 17.0+7.2 21.0 + 18.3 
Ammonia 720.2 + 223.0 549.0 + 120.1 592.4 + 74.8 643.4 + 79.2 
Hydroxylysine Below Below Below Below detection levels detection levels detection levels detection levels 
Ornithine 290.3 + 74.9 182.7 + 85.2 165.7 + 33.7 231.3 + 71.4 
Lysine 625.6 + 132.4 601.7+311.9 753.0 + 138.1 727.8 + 167.7 
Histidine Below Below Below Below detection levels detection levels detection levels detection levels 
3-Methylhistidine 502.1 + 112.8 349.0 + 178.0 463.8 + 25.9 377.3 + 40.4 
Arginine 3.5 + 0.5 a 7.1 + 4.5 a 37.4 + 22.6 D 43.1 + 17.7 D 
Cystathionine 32.9 + 8.2 a 79.6 + 48.7 D 20.8 + 1.2 c 80.9 + 27.1 D 
Homocysteine Below Below Below Below detection levels detection levels detection levels detection levels 
Table 3.5b: The Effect of Varying Dietary Sulfur Amino Acid Concentrations 
on Hepatic Amino Acid Concentrations in Adult Male Sprague-Dawley Rats. 
All metabolites are expressed as ~mol/g wet weight. 
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3.2.2.3 Remethylation 
Few conclusions can be drawn regarding remethylation rates. The high 
methionine diets did not alter the measured in vitro activity of methionine 
synthase or of MTHFR; however, it is likely that, in vivo, the elevated SAM levels 
would have inhibited MTHFR and, therefore, curtailed folate-dependent 
remethylation. The high methionine diet decreased the activity of BHMT, but this 
was not evident in the animals fed the high methionine plus cystine diets. The 
relevance of this observation is not immediately apparent. 
3.2.2.4 Amino Acids 
The High Methionine group, the High Cystine group, and the High 
Methionine + Cystine group all displayed an increase of approximately 125% in 
hepatic taurine concentrations over the Low SAA group. These differences are 
also represented in the plasma taurine levels. The increased taurine reflects the 
increased availability of cysteine in these groups. 
While examining our amino acid data, it was discovered that the branched 
chain amino acids were seemingly affected by sulfur amino acid 
supplementation. In plasma, it was found that a methionine supplement 
decreased valine, isoleucine, and leucine concentrations by almost 35-40% 
(Table 3.4) . This finding was also evident in our hepatic branched chain amino 
acid analysis (Table 3.5). 
Since all three BCAA amino acids decrease with the high methionine 
supplement, it is likely that some aspect of methionine metabolism affects the 
common catabolic pathway that the BCAA share. This pathway consists of a 
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transamination by branched chain aminotransferase, followed by a 
decarboxylation by the branched chain a-ketoacid dehydrogenase complex; the 
branched-chain a-keto acid dehydrogenase (BKCD) is recognized as the 
regulatory enzyme of BCAA catabolism. The BCKD is regulated by 
phosphorylation, with an active unphosphorylated form (Brosnan and Brosnan, 
2006). lnterconversion of phosphorylated and unphosphorylated forms is 
catalyzed by a specific kinase and phosphatase. The kinase is inhibited by the 
branched-chain a-keto acids, which ensures their catabolism. The kinase is also 
inhibited by a-ketomethionine and by a-ketobutyrate (Jones and Yeaman, 1986). 
a-ketomethionine may be expected to increase in rats fed a high methionine diet. 
So, too, may a-ketobutyrate levels, as may be inferred from the markedly 
increased levels of a-aminobutyrate (its transamination partner) in both the 
plasma and liver of these animals (Table 3.4-3.5) . One possible suggestion, 
therefore, is that activation of the BKCD brought about by one or both of these 
keto-acids may account for the decreased levels of the BCAA. 
Another possible reason for this decrease in BCAA in the high methionine 
diets could be due to the fact that all three are transported across the intestinal 
epithelial mucosa via the same neutral amino acid transporter (Broen eta/, 2005). 
It is possible that the high concentration of methionine could interfere with the 
absorption of the BCAA in the gut and, since all BCAA are essential and must 
come from the diet, would result in the lowered levels seen in the results. 
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3.2.2.5 Cystathionine [3-Synthase mRNA 
Figure 3.2 shows an increased CBS mRNA in the high methionine-fed 
group only, which was not reflected by in vitro activity. Additionally, a decrease in 
in vitro CBS activity was detected in our cystine-supplemented animals only, but 
was not reflected in our CBS mRNA analysis. In a paper published by 
Yamamoto, Tanaka, and Noguchi (1995), the effect of cystine on CBS activity 
and mRNA was examined. Adult rats (12 weeks) were fed diets containing 1.0% 
methionine + 0% cystine or 0.25% methionine + 2% cystine. These investigators 
also found a 40% decrease in activity, w ithout a significant change in CBS 
mRNA, much the same as the results of our experiment. It would seem, 
therefore, that the regulation of CBS activity in adult rats by cystine is likely via 
another mechanism than transcriptional control. 
3.2.2.6 Transsulfuration Flux in Hepatocytes 
We also examined the transsulfuration flux in hepatocytes from rats fed 
the low SAA diet and those fed a high cystine diet. There was no significant 
difference in transsulfuration flux at 1.0 mM 1-14C-methionine; however, when the 
hepatocytes were incubated with 0.1 mM 1-14C-methionine, there was a 
significant decrease of 35% in transsulfuration flux in hepatocytes prepared from 
rats fed the cystine-supplemented diet (Table 3.6). 
3.2.3 Conclusion 
The addition of a methionine supplement to a diet containing a minimal 
amount of sulfur amino acids stimulates flux through transmethylation and 
transsulfuration . Increased transmethylation is suggested by the increase in MAT 
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Figure 3.2: The Effect of Varying Dietary Sulfur Amino Acid Concentrations 
on Hepatic Cystathionine JJ-Synthase mRNA Concentrations. Figure 3.2a 
represents the Northern Blot, where LM = Low SAA, HM = High Methionine, C = 
High Cystine, and M+C = High Methionine + Cystine. The numbers 1 and 2 
represent sample animals from each diet group. Figure 3.2b represents the 
statistical analysis of the Northern Blot by comparing integrated density values; 
differing subscripts indicate significantly different results. 
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Transsulfuration Flux 
(nmol/30 min/mg dry weight) 
0.1 mM 1-14C-Methionine 
LowSAA Diet C~stine SUI!I!Iemented 
a.-Keto butyrate 0.92 + 0.27 a 0.59 + 0.22 a 
C02 2.22! 0.62 a 1.45! 0.39 a 
Total 3.11! 0.42 a 2.01! 0.29 b 
1.0 mM 1-14C-Methionine 
LowSAA Diet C~stine SUI!I!Iemented 
a.-Ketobutyrate 3.00! 0.31 b 2.33! 0.38 b 
C02 1.72 + 0.46 a 1.57! 0.35 a 
Total 4.72! 0.46 c 3.89! 0.68 c 
Table 3.6: The Effect of Varying Dietary Sulfur Amino Acid Concentrations 
on Transsulfuration Flux in Adult Sprague-Dawley Isolated Hepatocytes 
Incubated with 1.0 mM and 0.1 mM 1-14C-Methionine. Superscripts mark 
differences between the same groups of measurement. 
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activity and SAM and SAH concentrations. This increase in SAH would lead to 
an increase in liver homocysteine, resulting in a number of fates. The first fate 
that excess homocysteine may face would be transport into the plasma, and we 
observed that a high methionine supplement in the diet did, in fact lead to an 
increase in plasma homocysteine concentrations. The second fate would lead 
homocysteine through the remethylation pathway; however, due to excess 
methionine present in the cell , it is likely that the remethylation pathway would be 
inhibited. This would come about both by the decrease in BHMT activity as well 
as via inhibition of MTHFR by the increased SAM. Finally, homocysteine would 
be directed towards cysteine production via the transsulfuration pathway; we also 
saw evidence for this in terms of increased cystathionine and aminobutryate 
concentrations, CBS mRNA levels and taurine concentrations. 
Cystine supplementation in adult rats at these insufficient levels of 
methionine seemed to have little to no effect on methionine metabolism; 
however, in adult hepatocytes incubated with physiological levels of methionine, 
there was a decrease in transsulfuration flux, indicating that a methionine-sparing 
effect may still be present. 
The purpose of this study was to examine the growth rates of adult 
Sprague-Dawley rats and the possible sparing effect of cysteine on methionine 
requirements. While an effect on both growth and the sparing effect were noted 
in this experiment, adult rats do not grow as fast as young rats. Therefore, the 
question is raised - does the age of the test animal affect the methionine-sparing 
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effect of cysteine? Would the effect be more prominent in younger animals as 
compared to their adult counterparts? 
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3.3 The Effect of Varying Methionine and Cysteine Concentrations in the 
Diet on Methionine Metabolism in Young Sprague-Dawley Rats 
3.3.1 Background 
Cysteine spares the requirement for methionine in the adult rat. This 
sparing effect is likely via an effect on the transsulfuration pathway. The sparing 
effect is evident in vivo from the growth rates of the animals; diets insufficient in 
methionine result in reduced growth, though when supplemented with cystine, 
these same diets result in the identical growth as a high methionine diet. These 
growth studies were examined in adult rats, whereas the growth of young rats, 
which grow far faster than adult rats, has yet to be studied . Therefore, we 
examined the sparing effect of cysteine on methionine requirements in young 
Sprague-Dawley rats in an attempt to determine the potential mechanisms 
behind the cysteine-sparing effect. 
3.3.2 Results 
3.3.2.1 Growth Studies 
Each of the rats used for this experiment had an initial weight of 50-65g. 
After a three-day acclimatization period, their average weight was 69.25 2:. 5.95 g, 
which was followed by the one-week experimental diet-feeding period . On the 
day of sacrifice, the Low SAA group of rats had grown approximately 6 g from the 
day they were removed from the acclimatization diet, while the other three animal 
groups had grown approximately 49 g since that same day. A graphical 
representation of these results can be seen in Figure 3.3. 
91 
Figure 3.3: The Effect of Diets Containing Varying Dietary Sulfur Amino 
Acid Concentrations on Growth in Young Sprague-Dawley Rats. Figures 
3.3a and 3.3b show, respectively, the final body weight and the 7-day weight gain 
in g; Figure 3.3c demonstrates the growth over the entire feeding period 
(including the acclimation period). The vertical line in Figure 3.3c represents the 
end of the acclimation period and the beginning of the seven-day feeding period . 
Different subscripts represent significant differences among groups. 
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3.3.2.2 Methionine Supplementation 
Similar to our adult rats, a methionine supplement increases the activity of 
MAT (Table 3.7) while simultaneously increasing the hepatic concentrations of 
SAM, SAH and methionine, as well as plasma tHey (Table 3.8), which, together, 
indicates an increase in transmethylation. In contrast to our adult rats, there was 
no change in hepatic sarcosine levels, and unfortunately, plasma sarcosine 
concentrations were unable to be measured. 
The increased catabolism of excess homocysteine through the 
transsulfuration pathway is evident in our young rats as well as the adults, as 
methionine supplements increased hepatic cystathionine levels (Table 3.8). 
Additionally, though not seen in the adult rats, methionine intake was also 
associated with increased CBS activity (Table 3.7) and CBS mRNA (Figure 3.4) . 
Methionine supplementation had no effect on the activity of either MS or 
MTHFR; however, as with the adult rats, it is likely that increased SAM 
concentrations would Increase MTHFR activity, thereby increasing the 
remethylation of homocysteine to methionine. Methionine supplementation alone 
also decreased BHMT activity, thereby slowing the remethylation of 
homocysteine to methionine. 
3.3.2.3 Cystine Supplementation 
Cystine supplementation alone has no effect on CBS activity; however, 
cystine can modify the increase in CBS activity seen with a methionine 
supplement (Table 3.7). Cystine does have an effect on CBS mRNA that is not 
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ENZYME High High 
ACTIVITY Low SAA Methionine High Cystine Methionine and Cystine 
MAT 
nmol/min/g 194.5 ± 25.5 342.5 ± 65.3 190.5 + 19.6 330.0 ± 28.7 
liver a b a b 
nmol/min/mg 2.23 ± 0.24 3.26 ± 0.57 1.98±0.16 3.46 ± 0.27 
protein a b a b 
GNMT 
nmol/min/g 854.4 ± 90.1 1030.0 ± 1031.0 ± 1125.0 ± liver 253.7 170.3 283.4 
nmol/min/mg 4.35 ± 0.47 5.16 ± 0.57 4.35 ± 0.34 5.34 ± 0.83 protein 
CBS 
nmol/min/g 0.47 ± 0.07 1.04 ± 0.14 0.54 ± 0.04 0.81 ± 0.02 
liver a b a c 
nmol/min/mg 5.33 ± 0.67 10.83 ± 0.85 5.60 ± 0.45 7.78± 0.59 
protein a b a c 
CGL 
nmol/min/g 1601 ± 126 3322 ± 483 2456 ± 207 2214 ± 676 
liver a b a a 
nmol/min/mg 18.17 ± 1.36 34.77 ± 4.92 25.59 :t2.89 21.20 ± 6.66 
protein a b a a 
Table 3.7a: The Effect of Varying Dietary Concentrations on Hepatic 
Enzyme Activities of Methionine Metabolism in Young Sprague-Dawley 
Rats. All enzyme activities are presented in both nmol/min/g liver and 
nmol/min/mg protein. (MAT = Methionine Adenosyltransferase; GNMT = Glycine 
N-Methyltransferase; CBS = Cystathionine 13-Synthase; CGL = Cystathionine y-
Lyase). Different subscripts represent significantly different values within groups. 
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ENZYME High High 
ACTIVITY Low SAA Methionine High Cystine Methionine 
and Cystine 
MS 
nmol/min/g 11.70 2: 0.53 10.05 2: 0. 76 13.24 2: 2.97 10.39 2: 3.01 liver 
nmollmin/mg 0.133 2: 0.009 0.097 2: 0.011 0.136 2: 0.024 0.109 2:0.031 protein 
MTHFR 
nmollmin/g 0.061 2: 0.029 0.086 + 0.041 0.060 + 0.046 0.103 2:0.041 liver 
nmollmin/mg 0.242 2: 0.061 0.286 2:0.073 0.231 2: 0.096 0.317 2: 0.068 protein 
BHMT 
nmollmin/g 80.46 2: 5.29 35.58 2: 17.97 103.8 + 14.12 136.6 2: 39.28 
liver a b c c 
nmollmin/mg 0.914 2: 0.621 0.332 2: 0.150 1 . 167 2: 0.150 1.441 2: 0.465 
protein a b ac c 
CHDH 
nmol/min/g 8.52 2: 1.69 9.08 2:2.70 13.01 2: 3.80 9.25 2: 1.00 liver 
nmol/min/mg 0.240 + 0.044 0.251 2: 0.051 0.318 + 0.126 0.249 2: 0.032 protein 
Table 3.7b: The Effect of Varying Dietary Concentrations on Hepatic 
Enzyme Activities of Methionine Metabolism in Young Sprague-Dawley 
Rats. All enzyme activities are presented in both nmollmin/g liver and 
nmollmin/mg protein. (MS = Methionine Synthase; MTHFR = 
Methylenetetrahydrofolate Reductase; BHMT = Betaine:Homocysteine 
Methyltransferase; CHDH = Choline Dehydrogenase). Different subscripts 
represent significantly different results within groups. 
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High High Substrate Low SAA High Cystine Methionine Methionine 
and Cystine 
Plasma Metabolites {J.1Mj 
Methionine 20.90 ± 3.65 a 90.70 + 20.03 17.50 ± 6.38 a 57.90 ± 8.05 c o 
Homocysteine 8.17 + 0.42 a 19.07 + 4.56 D 6.55 + 2.87 a 22.69 + 2.92 b 
Cysteine 56.96 + 4.85 46.31 + 7.50 50.68 + 10.45 44.70 + 9.75 
Cys-Giy 11.81 + 1.98 a 1.66 + 1.94 D 1.99 + 0.36 D 2.06 + 0.56 b 
Glutathione 41.58 + 4.37 a 35.99 + 4.50 a 22.19 + 7.92 D 27.09 + 2.36 D 
Liver Metabolites (nmoles~ 
Methionine 56.1 + 11.6 a 121.0 + 23.8 D 80.6 + 20.9 a 118.3 + 23.4 b 
SAM 62.1 + 5.2a 155.4 + 21.6° 35.9 + 20.5a 125.1 + 33.1b 
SAH 6.7 + 0.7a 14.3 + 4.3° 5.4 + 3.7a 14.6+4.1b 
Homocysteine ... 2.5 ... 2.5 ... 2.5 ... 2.5 
Cystathionine 68.9 ± 21.5 a 225.1 + 101 .5 44.7 ± 41.5 a 218.0 ± 36.3 b o 
Cysteine 25.5 + 1.9 a 69.6 + 8.0 b 98.2 + 62.8 D 92.5 + 19.5° 
Table 3.8: The Effect of Varying Dietary Sulfur Amino Acid Concentrations 
on Substrates and Products in the Metabolism of Methionine in Young 
Sprague-Dawley Rats. SAM = S-Adenosylmethionine; SAH = S-
Adenosylhomocysteine. All subscripts indicate significantly different results 
within groups. 
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Figure 3.4: The Effect of Varying Dietary Concentrations of Sulfur Amino 
Acids on Hepatic Cystathionine J3-Syntha~e mRNA in Young Sprague-
Dawley Rats. Figure 3.4a displays a sample Northern blot. Lane 1 contains the 
High Cystine sample; Lane 2 contains High Methionine; Lane 3 contains High 
Methionine + Cystine; and Lane 4 contains Low SAA. Figure 3.4b displays the 
statistical analysis of the Northern , standardized with ~-actin , in terms of IDV. 
98 
<( 
z 
~CBS~ 
B-actin 
mRNA 
100000 
75000 
o::s; 
Ec 
en::.. 50000 
Ill 
0 
25000 
0 
c 
-
-
- a 
-...-
-
_.__ 
M M+C 
b 
-,...--
d 
--
-...-
c 
--
-'--
--
(J~~ 
X 
0--~ 
Supplement 
Low 
SAA 
99 
Table 3.9: The Effect of Varying Dietary Sulfur Amino Acid Levels on 
Plasma Amino Acid Concentrations in Young Sprague-Dawley Rats. All 
values are presented in terms of IJM. Significantly different results within groups 
are indicated with different subscripts. 
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Plasma High High Low SAA High Cystine Methionine and Metabolite Methionine Cystine 
Taurine 58.8 ± 2.4 a 122.8 + 20.0 179.5 ± 32.4 b 223.6 ± 69.3 c ab 
Urea 4583.3 ± 3689.1 ± 4080.9 + 11292.4 + 745.6 627.5 1011.8 7725.2 
Aspartic Acid 16.9 + 1."9 23.2 + 5.0 23.6 + 4.4 20.5 + 2.9 
Hydroxyproline 18.1 + 5.2 33.1 + 8.7 31.1+8.3 33.1 + 13.2 
Threonine 394.9 + 55.1 a 219.2 + 43.1 D 168.3 + 48.0 b 174.6 + 45.4 b 
Serine 287.8 + 42.9 a 145.8 + 23.3 D 148.7 + 46.1 D 119.3 + 17.5 b 
Asparagine 54.8 + 18.9 91 .0 + 30.6 75.7 + 31.0 64.3 + 19.2 
Glutamic Acid 72.1 + 14.6 97.1 + 21 .9 96.3 + 18.6 90.5 + 25.9 
Glutamine 389.5 + 44.9 355.4 + 71.9 329.9 + 101.7 279.4 + 49.7 
Below Below Below Below Sarcosine detectable detectable detectable detectable levels levels levels levels 
Proline 107.7 + 21 .0 141.9 + 23.8 113.6 + 36.9 102.8 + 21.6 
Glycine 445.4 + 50.5 644.1 + 153.2 633.9 + 178.0 575.6 + 149.3 
Alanine 497.1 ± 111 .5 639.7 ± 166.4 589.8 ± 133.9 457.0 ± 100.5 a a 
Citruline 58.1 + 4.2 58.8 + 4.0 52.0 + 11 .9 52.9 + 13.4 
a-Ami no-n- 8.4 ± 5.0 15.3 ± 4.2 6.4 ± 9.0 8.4 ± 4.9 butyric Acid 
Valine 156.9 + 52.1 128.8 + 8.8 120.9 + 35.8 126.4 + 12.0 
Methionine 22.2 + 5.7 a 90.7 + 20.0 D 17.5 + 6.4 a 57.9 + 8.1 c 
Isoleucine 76.6 + 24.7 91.9 + 12.3 80.0 + 14.9 72.8 + 5.0 
Leucine 98.7 + 22.9 a 50.6 + 14.3 b 44.4 + 28.1 b 61.5 + 14.4 b 
Tyrosine 45.6 + 7.8 56.6 + 23.7 50.0 + 14.6 40.8 + 9.2 
Phenylalanine 40.1 + 9.1 41 .9+10.8 37.0 + 4.8 40.7 + 6.9 
Tryptophan 43.5 + 15.5 53.4 + 5.1 47.5 + 5.6 49.3 + 7.5 
Ethanolamine 9.5 + 1.3 8.7 + 0.9 6.8 + 2.6 7.0 + 6.5 
Ammonia 81.8 + 12.3 86.0 + 10.4 165.1 + 67.5 107.1 + 76.8 
Hydroxy lysine Trace Trace Trace Trace 
Ornithine 73.7 + 13.7 103.8 + 86.1 67.6 + 24.2 72.7 + 61 .5 
Lysine 409.9 + 115.1a 233.3 + 89.8 D 242.0 + 20.7 b 151 .7 + 101 .7 b 
Histidine 50.9 + 2.8 a 32.6 + 6.0 b 24.3 + 4.2 b 21.3+15.0° 
3- Trace Trace Trace Trace Methyl histidine 
Arginine 104.0 + 33.8 111 .3 + 69.3 116.3 + 36.0 50.3 + 45.0 
Cystathionine Trace 2.3 + 0.5 Trace 2.0 + 0.8 
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Liver High High 
Metabolite Low SAA Methionine High Cystine Methionine 
and Cystine 
Taurine 1026.1 .± 365.9. 8125.6 + 2338.9 8157.1 + 2608.3 8227.0 .± 933.4 b 'D 'D 
Urea 19641.4 + 243082.2 + 321586.6 + 992805.1 + 2059.4 8 88302.2 I) 193387.6 ° 184796.1° 
Aspartic Acid 1842.4 .± 134.0 8 3534.8 .± 353.7 b 4012.7 + 1054.2 2796.9 + 1086.5 'D 'D 
Hydroxyproline Below Below Below Below detectable levels detectable levels detectable levels detectable levels 
Threonine 1110.5 + 279.7. 241 .8 + 77.3 u 376.0 + 148.2 D 217.3 + 47.0 ts 
Serine 2317.0 + 267.7. 407.2 + 76.5 D 679.9 + 293.4 D 354.0 + 54.1 D 
Asparagine 89.3 + 12.9 59.5 + 20.8 61 .7 + 13.9 60.2 + 19.1 
Glutamic Acid 1648.4 .± 254.3 8 1179.6 + 159.3 1250.0 + 360.1 921 .2 .± 217.2 b ID all 
Glutamine 3999.3 + 980.5 3984.5 + 294.2 4459.2 + 1663.0 3428.8 + 360.7 
Sarcosine 56.0 + 25.6 42.4 + 48.9 53.8 + 44.6 76.8 + 75.8 
Proline 157.3 + 48.6 306.4 + 77.1 267.9 + 174.8 292.7 + 181.8 
Glycine 2468.6 + 594.2 2398.7 + 226.7 2874.7 + 950.5 2022.2 + 293.7 
Alanine 3381.4 + 1475.3 31 59.8 + 813.4 3502.8 + 1412.7 2841 .9 + 315.9 
Citruline 74.7 + 16.3 .. 48.0 + 15.6 u 40.2 + 4.1 u 36.9 + 5.9 D 
a-Amino-n-butyric 18.4 .± 5.2 37.0 .± 2 .5 28.3 .± 19.7 30.6 .± 7.4 Acid 
Valine 165.5 + 32.0 168.8 + 50.9 201 .1+85.5 135.7 + 34.8 
Table 3.10a: The Effect of Varying Dietary Sulfur Amino Acid 
Concentrations on Hepatic Amino Acid Concentrations in Young Sprague-
Dawley Rats. All values are presented in terms of 1Jmol/g wet weight. 
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Liver High High Low SAA High Cystine Methionine Metabolite Methionine 
and Cystine 
Cysteine 98.8 + 9.7 103.7 + 18.3 105.5 + 25.4 94.2 + 25.2 
Methionine 22.4 + 4.6 a 48.2 + 9.8 D 32.2 + 8.4 a 47.3 + 9.4 D 
Isoleucine 101.8.:!: 116.8_±39.1 135.7.:!: 43.0 108.5_±31.1 13.9 
Leucine 157.6.:!: 117.6.:!: 55.9 134.0.:!: 49.9 106.7.:!: 49.2 15.9 
Tyrosine 97.7+12.1 89.8 + 10.1 94.0 + 32.9 72.8 + 16.2 
Phenylalanine 65.2 + 9.1 69.0 + 17.2 68.7 + 21.5 63.1+10.8 
Tryptophan Trace Trace Trace Trace 
Ethanolamine Trace a 18.0+12.1° 20.6 + 19.2 b 14.7 + 8.1 b 
Ammonia 819.6.:!: 711.1.:!: 90.8 791.4 .:!: 256.6 667.1 .:!: 161.2 123.8 
Hydroxy lysine Trace Trace Trace Trace 
Ornithine 463.8.:!: 148.9.:!: 65.8 b 162.1 + 105.4 124.1 .:!: 38.9 b 181.1 a "6' 
Lysine 792.3.:!: 790.3 .±205.0 821 . 1 .:!: 331 . 7 706.5 .:!: 115.3 139.4 
3-Methylhistidine 0 0 0 0 
Histidine 50.0 + 2.8 32.6 + 6.0 24.3 + 4.2 21.4 + 15.0 
Arginine 72.7 + 22.4 66.7 + 9.1 74.0 + 27.3 62.5 + 7.2 
Cystathionine 27.6 + 8.6 a 89.8 + 40.6 D 17.9 + 16.6 a 87.2 + 14.5 D 
Homocysteine Trace Trace Trace Trace 
Table 3.10b: The Effect of Varying Dietary Sulfur Amino Acid 
Concentrations on Hepatic Amino Acid Concentrations in Young Sprague-
Dawley Rats. All values are presented in terms of j.lmol/g wet weight. 
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seen in adult rats; a cystine supplementation decreases CBS mRNA both with 
(55% decrease) and without (45% decrease) methionine supplementation (Figure 
3.3). The dectease in CBS mRNA seen with a cystine supplement is similar to 
the decrease in CBS mRNA seen by Yamamoto et a/ in 1995, when they 
demonstrated a 60% decrease in CBS mRNA when comparing rats fed a 1.0% 
methionine supplemented diet and a 1.0% methionine + 0.25% cystine 
supplemented diet. 
One inexplicable result from our experiment that was not seen in our adult 
experiment was a decrease in BHMT activity when supplemented with 
methionine, yet a joint methionine-cystine supplement resulted in an increase in 
activity. We have no explanation for this discrepancy at this time. 
3.2.2.4 Amino Acids 
As with the adult rats, both plasma and hepatic taurine concentrations 
increased with methionine and/or cystine supplementation, which indicates an 
increase in the availability of cysteine in these groups (Table 3.9 and 3.10). 
There was no change in BCAA in the young rats as compared to the 
decrease in BCAA seen with methionine supplementation with adult rats (Table 
3.1 0). As previously discussed, a-aminobutyrate concentrations can indicate a-
ketobutyrate levels, which may, in turn, activate the process by which BCAA are 
catabolised - in our young rats, a-aminobutyrate concentrations show no 
significant changes. Additionally, the plasma and hepatic methionine levels in 
our young rats, though increased with methionine supplementation, do not 
approach the concentrations seen in adult rats with methionine supplementation. 
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It is therefore possible that there is insufficient a-ketomethionine and/or a -
aminobutyrate formed to activate the BCAA catabolism process. 
In this experiment, when supplemental sulfur amino acids were provided, 
we observed a decrease in plasma threonine, serine, leucine, lysine and histidine 
(Table 3.1 0), as well as a decrease in hepatic threonine and serine (Table 3.9). It 
is possible that this decrease is due to a resultant increase in protein synthesis 
that would occur when sufficient sulfur amino acids are added to the amino acid 
pool in the growing rats. This greatly stimulated protein synthesis would also 
explain why these decreases were not noticed in the adult rats. 
3.2.2.5 Transsulfuration Flux in Hepatocytes 
There was no difference in transsulfuration flux between the four animal 
groups when hepatocytes were incubated with 1.0 mM 1-14C-methionine; 
however, when incubated with the more physiological 0.1 mM concentration, the 
transsulfuration flux was reduced by about 65% in hepatocytes from rats fed the 
cystine supplement (Figure 3.5). A similar finding was evident in rats fed a 
supplement of both amino acids, while the methionine supplement was without 
effect. 
When examining our transsulfuration flux experiments, it is interesting to 
' 
note that all the changes that occur in our measurements are due to changes in 
the recovery of 14C02, and not in the recovery of a-ketobutyrate. While it is 
possible that these changes have some biochemical relationship to the SAA, it is 
more likely that a-ketobutyrate very efficiently is transported into the mitochondria 
to be metabolized to C02. 
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3.3.3 Conclusions 
When a methionine supplement is added to a Low SAA diet, the 
metabolism of methionine undergoes a shift towards transsulfuration. The 
additional methionine results in higher concentrations of methionine in the liver, 
which, in turn, increases the rate of the transmethylation reactions. This 
increased transmethylation results in the production of larger concentrations of 
homocysteine, which are either transported into the plasma or used to synthesis 
cysteine via the transsulfuration pathway. The remethylation pathway, the third 
potential fate of homocysteine, will become reduced in activity due to the excess 
of methionine already present. On the other hand, transsulfuration will increase, 
as indicated by increased cystathionine, cysteine, and taurine levels. 
When cystine is added to the Low SAA diet, there is no effect on the 
transmethylation pathway. The transsulfuration pathway, however, decreases its 
activity, as seen by the decrease in CBS mRNA and a decrease in 
transsulfuration flux in isolated hepatocytes. It seems that the decrease in 
transsulfuration is responsible for the methionine-sparing effect of cystine 
supplementation, as can be seen by the comparable growth rates of the High 
Cystine animals and the High Methionine animals. 
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Figure 3.5: The Effect of Varying Dietary Sulfur Amino Acid Concentrations 
on Transsulfuration Flux in Young Sprague-Dawley Rats. The red sections 
refer to the 14C in a-ketobutyrate, while the blue sections refer to the 14C02 
produced. The sum of these two results is the total flux through transsulfuration. 
The results are produced in terms of nmoi14C02/30 min/g dry liver. 
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3.4 The Effect of Allosteric Regulators on Key Enzymes of Methionine 
Metabolism 
3.4.1 Background 
While metabolism of methionine is regulated by a variety of means, one of 
the more interesting mechanisms is via allosteric regulation, and specifically, that 
by SAM and SAH. It has been shown previously that SAM and SAH levels can 
affect the enzyme activities of several of the key enzymes of methionine 
metabolism, such as MTHFR (Jencks eta/, 1987), CBS (Finkelstein eta/, 1975; 
Finkelstein eta/, 1974), and BHMT (Finkelstein and Martin, 1984). 
In the previous two experiments, we analyzed both enzyme activities and 
in vivo concentrations of SAM and SAH. Due to the wide range of SAM and SAH 
concentrations found in the different experiments, we decided to make a 
definitive study of the effect of these regulators on the enzyme activities. We ran 
liver cytosol though PD-1 0 desalting columns. This permits the proteins to be 
eluted in the void volumes while the columns retain small molecules such as 
SAM and SAH. MTHFR, CBS, and BHMT were assayed as a function of [SAM] 
while the dependence of CBS on [SAH] was also examined. 
3.4.2 Results 
3.4.2.1 SAM and SAH Analysis 
We first determined the effectiveness of the PD-1 0 columns in removing 
SAM and SAH. This was done by analyzing, via HPLC, a liver cytosol sample 
that had been through the PD-10 column. Figure 3.6 shows a chromatogram in 
which just SAM and SAH were run . SAM had a retention time of 16.98 minutes, 
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while SAH had a retention time of 15.74 minutes. Analysis of the liver cytosol 
sample that had been run through the PD-10 column showed no discernable 
SAM and SAH peaks at either 15 or 17 minutes, thereby indicating that SAM and 
SAH were effectively eliminated by the run through the PD-1 0 column (Figure 
3.7) 
3.4.2.2 SAM, SAH and Cystathionine J3-Synthase 
There was a sigmoidal relationship between [SAM] and CBS activity 
(Figure 3.8). The Ka of CBS for SAM was determined to be 243.3 ~M. There 
was no significant effect of [SAH] on CBS activity up to 250 ~M - this was the 
maximal concentration that we could use as SAH was not soluble in larger 
concentrations. 
3.4.2.3 SAM and the Remethylation Pathway 
MTHFR activity in these liver cytosols was inhibited by SAM with a 50% 
inhibition evident at 185.6 ~M (Fig. 3.9). In contrast to previously published 
reports, we found no inhibition of BHMT by SAM (Fig. 3.1 0). 
3.4.3 Discussion 
The existence of a SAM-regulated metabolic switch has been postulated 
since Finkelstein (1974) investigated the regulatory properties of SAM. The 
SAM-switch could determine whether methionine metabolism is function ing in a 
methionine catabolism mode (where the enzymes are designed to send 
methionine through the transmethylation and transsulfuration pathways) or in 
methionine conservation mode, where the flux through the transmethylation 
pathway is reduced, and flux through the remethylation pathway is increased. 
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Figure 3.6: Measurement of a standard 10 JJM solution of S-
Adenosylmethionine and S-Adenosylhomocysteine by HPLC. SAH appears 
at a retention time of 15.74, while SAM appears at a retention time of 16.98. 
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Figure 3.7: Determination of SAM and SAH Concentrations in Liver Cytosol 
after Elution from a PD-1 0 Desalting Column. As previously shown, ·sAM and 
SAH have a retention time of 16.98 and 15.74, respectively; neither peak appears 
on this sample readout. 
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Figure 3.8: The Effect of Increasing Concentrations of SAM and SAH on 
Cystathionine 13-Synthase Activity. Figure 3.8a shows the effect of SAM on 
CBS activity; note that the Ka was determined to be 243.3 JJM. Figure 3.8b 
demonstrates the effect that SAH concentrations have on CBS activity. (n = 4; 
error bars indicate standard deviation) 
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Figure 3.9: The Effect of Varying SAM Concentrations on 
Methylenetetrahydrofolate Reductase Activity. MTHFR activity is measured 
as a percentage of basal activity, while SAM concentrations are measured in 1-JM. 
(n = 4; error bars indicate standard deviation) 
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Figure 3.10: The Effect of SAM Concentrations on Betaine:Homocysteine 
Methyltransferase. Enzyme activity is measured in terms of percentage of basal 
activity, while SAM concentrations are measured in IJM. (n = 4; error bars 
indicate standard deviation) 
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It is instructive to apply these data on the sensitivity of key enzymes to 
SAM concentrations to the levels of these metabolites reported earlier in this 
thesis. So as to convert our earlier data to intracellular concentrations, we will 
employ the data of Quan and Brown (1996) that reported that one gram of rat 
liver contains about 0.45 ml of intrahepatocellular water. Our data in Table 3.3 
showed that hepatic SAM levels are about 80 nmole/g and, in those adult rats fed 
the methionine supplement, about 575 nmole/g. These would translate into 
intracellular concentrations of 180 1-1M and 1300 IJM, respectively, assuming that 
SAM were equally distributed through intracellular water. The corresponding 
concentration for the young rats (Table 3.8) would be about 150 IJM in the rats 
fed no supplemental methionine and about 300 1-1M in those who received this 
supplement. Comparing these numbers to the data in Figures 3.8 and 3.9, it is 
apparent that the allosteric effects of SAM would be manifest in all of these 
animals. Even in rats fed a SAA deficient diet, sufficient SAM would be present 
in hepatocytes to activate CBS to about 175% of the basal rate and to inhibit 
MTHFR by about 50%. When rats were fed the methionine-supplemented diets, 
there would be sufficient intracellular SAM to fully activate CBS (to almost 300% 
of the basal rate) and to inhibit MTHFR by more than 60%. Of course, the actual 
activities of these enzymes will depend on other factors, in particular on substrate 
concentrations. Nevertheless, these calculations clearly demonstrate the 
importance of intracellular SAM levels to the regulation of these pathways and , 
somewhat surprisingly, suggest that these regulatory effects are important even 
in animals fed insufficient methionine. 
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Based on our data on CBS and MTHFR, two rate-limiting enzymes in their 
respective pathways, it would seem that this SAM-switch may be optimally active 
at about 200 IJM, or approximately 90 nmol/g liver. Both the activation of CBS 
and the inhibition of MTHFR are about 50% effective at this concentration. 
One interesting aspect of this study is the lack of effect that SAM has on 
the activity of BHMT. Previous reports by Finkelstein and Mudd (1984) have 
indicated that increasing concentrations of SAM result in a decreased flux 
through the BHMT enzyme. This disparity between the two branches of the 
remethylation pathway creates a situation where one branch, the MTHFR/MS 
branch, is dependent on SAM for regulation, while the other branch, consisting of 
betaine metabolism, is SAM independent. 
The fact that the betaine branch of remethylation is unaffected by SAM 
poses an interesting question - why is one branch of remethylation affected by 
SAM, yet not the other? The explanation for this could simply be that the 
remethylation pathways have two different functions - the folate remethylation 
pathway could be responsible for the maintenance of SAM concentrations in the 
hepatocyte, while the betaine remethylation pathway could be responsible for 
something completely different, the catabolism of choline and betaine. In this 
scenario, a lowered SAM level would result in increased flux through the folate 
remethylation pathway, creating more SAM for the hepatocyte. However, there is 
no reason why the catabolism of choline and betaine should be regulated by 
SAM levels. 
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3.4.4 Conclusion 
After examining the key regulatory enzymes in the remethylation and 
transsulfuration pathway, it is clear that SAM does have profound effects on both 
these pathways, as CBS activity increases exponentially with the addition of 
SAM, while MTHFR decreases exponentially. The midpoint of both of these 
regulatory curves is at approximately 200 1-1M SAM, indicating that this may be 
the approximate concentration for the hypothesized "SAM switch" that can 
change the methionine metabolic pathways from methionine conservation to 
methionine expenditure. Finally, the fact that BHMT seems to be unaffected by 
SAM concentrations leads one to believe that the branches of remethylation have 
two different purposes: the folate remethylation pathway may be used to 
replenish intracellular SAM requirements, while the betaine remethylation 
pathway is primarily for the catabolism of choline and betaine. 
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